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SLIPPING THROUGH THE CRACKS: WHY
 
CAN’T WE STOP DRUGGED DRIVING?
 
TINA WESCOTT CAFARO* 
If you think about the dangerous people you share the road­
ways with when you get behind the wheel of your car and drive, you 
will likely consider the inattentive driver, the unskilled driver, the 
reckless driver, the cell-phone-talking-and-texting driver, and the 
drunk driver.  But, how often do you contemplate a scenario where 
the driver of the vehicle next to you is under the influence of drugs? 
Many would argue not often enough.1  Little is heard of the danger­
ous crime of operating a motor vehicle while under the influence of 
drugs (OUI drugs), also called drugged driving.  This lack of aware­
ness is attributable, at least in part, to the focus on curtailing 
alcohol-impaired driving over the last twenty years.2 
Efforts to stop alcohol-impaired driving include numerous 
public-awareness campaigns,3 the expenditure of millions of dollars 
* Clinical Professor of Law, Western New England College School of Law.  I 
would like to express my deep appreciation to Lauren Carasik for reading earlier drafts 
of this article and offering advice.  I also wish to thank Martha Santoro, Renee Ras­
torfer, and Kaitlin Pinette for their research assistance. 
1. Melanie Marciano, Drug-Influenced Driving a Growing Hazard, UPI PERSPEC­
TIVES, Dec. 2, 2004 (“There is a great deal of ignorance about drug impaired driving.” 
(quoting the Director of the Office of National Drug Control Policy (ONDCP), John 
Walters)); see also INST. OF  BEHAVIOR & HEALTH, INC., IBH PUBLIC  POLICY  STATE­
MENT REGARDING DRUGGED DRIVERS, http://www.druggeddriving.org/pdfs/IBHPublic 
PolicyonDruggedDriving715.pdf (last visited Apr. 8, 2010) [hereinafter IBH PUBLIC 
POLICY STATEMENT]. 
2. See R.K. JONES ET AL., NAT’L HIGHWAY TRAFFIC SAFETY ADMIN., U.S. DEP’T 
OF TRANSP., STATE OF KNOWLEDGE OF DRUG-IMPAIRED DRIVING 9-10 (2003), availa­
ble at http://www.nhtsa.dot.gov/people/injury/research/StateofKnwlegeDrugs/Stateof 
KnwlegeDrugs/pages/3Detection.html [hereinafter STATE OF  KNOWLEDGE OF  DRUG­
IMPAIRED DRIVING]. 
3. See WORKING GROUP ON ILLEGAL DRUGS & DRIVING, INT’L COUNCIL ON AL­
COHOL, DRUGS & TRAFFIC  SAFETY, WORKING  GROUP  REPORT—“ILLEGAL  DRUGS 
AND  DRIVING” 56-64 (2000), http://www.icadts.org/reports/Drugs-FinalReport.pdf 
[hereinafter WORKING  GROUP  REPORT].  Organizations such as MADD and SADD 
have long been working publicly to prevent the occurrence of this crime. See Mothers 
Against Drunk Driving, Mission Statement, http://www.madd.org/About-us/About-us/ 
Mission-Statement.aspx (last visited Apr. 8, 2010); Students Against Destructive Deci­
sions, SADD History, http://www.sadd.org/history.htm (last visited Apr. 8, 2010).  Na­
tional campaigns promoted by the National Highway Traffic Safety Administration 
33 
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by both the government and private organizations,4 the demand for 
strict new legislation, and nation-wide implementation of uniform 
laws.  While this has by no means eradicated the crime of alcohol-
impaired driving, it has reduced the number of deaths on the high­
ways.5  Unfortunately, the same focus has not been placed on stop­
ping individuals from using drugs and driving a car.  Typically, drugs 
are used for medicinal purposes, but some are also used for recrea­
tional purposes, mostly because of their psychoactive properties. 
(NHTSA) and the Presidential Commission on Drunk Driving remind motorists that 
“Friends Don’t Let Friends Drive Drunk” and “You Drink & Drive. You Lose.” See 
WORKING GROUP REPORT, supra, at 57; Ad Council, Drunk Driving Prevention (1983­
Present), www.adcouncil.org/default.aspx?id=137 (last visited Apr. 8, 2010). 
The goal of You Drink & Drive. You Lose. [was] to enhance national aware­
ness about the deadly toll drinking and driving exacts on America’s communi­
ties and to generate a greater national urgency to stop the senseless killing and 
injury on our nation’s highways, in support of the national goal to reduce alco­
hol-related traffic fatalities to no more than 11,000by [sic] the year 2005. 
WORKING GROUP REPORT, supra, at 57; see also Mothers Against Drunk Driving, Me­
dia Center, http://www.madd.org/Media-Center/Media-Center/Media-Library/ 
PSAs.aspx (last visited Apr. 8, 2010) (providing examples of television, radio, and print 
ads). 
4. See T.J. ZWICKER ET AL., NAT’L  HIGHWAY  TRAFFIC  SAFETY  ADMIN., U.S. 
DEP’T OF  TRANSP., CONNECTICUT’S 2003 IMPAIRED-DRIVING  HIGH-VISIBILITY  EN­
FORCEMENT CAMPAIGN, at iv (2007) (stating that in 2003 “Congress appropriated $11 
million for paid media”).  In 2005, the budget proposal for impaired driving was $9.9 
million. National Highway Traffic Safety Administration’s Budget Request for Fiscal 
Year 2005: Hearings Before the Subcomm. on Transportation, Treasury, and Independent 
Agencies of the H. Comm. on Appropriations, 105th Cong. 7 (2004) (statement of Jef­
frey W. Runge, Adm’r, Nat’l Highway Traffic Safety Admin.), available at http://www. 
nhtsa.dot.gov/nhtsa/announce/testimony/2005BudgetRequestTestimony.pdf.  For infor­
mation on MADD’s finances, see MOTHERS  AGAINST  DRUNK  DRIVING, ANNUAL 
REPORT  FISCAL  YEAR 2007-2008, at 7 (2009), http://www.madd.org/getattachment/71 
9560b1-b2c2-4bac-a35e-baf7568080fa/2007-2008-Annual-Report—PDF.aspx; MOTHERS 
AGAINST  DRUNK  DRIVING, FINANCIAL  STATEMENTS AND  REPORT OF  INDEPENDENT 
CERTIFIED PUBLIC ACCOUNTANTS 2-6 (2008), http://www.madd.org/getdoc/1e18ffdb-2a 
36-44f2-8fa6-dc62056b0894/FSA---MADD---2008.aspx. 
5. See Mothers Against Drunk Driving, Campaign to Eliminate Drunk Driving— 
Statistics, http://www.madd.org/Drunk-Driving/Drunk-Driving/Statistics.aspx (last vis­
ited Apr. 8, 2010).  “Since 1980 (the year Mothers Against Drunk Driving was 
founded), alcohol-related traffic fatalities have decreased nearly 50 percent, from over 
30,000 to fewer than 15,500 . . . .” Id.  “In 2008, an estimated 11,773 people died in 
drunk driving related crashes—a decline of 9.8 percent from the 13,041 drunk driving 
related fatalities of 2007.” Id.; see also NAT’L HIGHWAY TRAFFIC SAFETY ADMIN., U.S. 
DEP’T OF TRANSP., 2006 TRAFFIC SAFETY ANNUAL ASSESSMENT—ALCOHOL-RELATED 
FATALITIES 1 (2007), http://www-nrd.nhtsa.dot.gov/Pubs/810821.PDF (stating that in 
2006, “17,602 people were killed in the United States in alcohol-related motor vehicle 
traffic crashes”). For an analysis and suggested explanations of this decline, see gener­
ally NAT’L HIGHWAY TRAFFIC SAFETY ADMIN., U.S. DEP’T OF TRANSP., STATISTICAL 
ANALYSIS OF  ALCOHOL-RELATED  DRIVING  TRENDS, 1982-2005 (2008), http://www-
nrd.nhtsa.dot.gov/Pubs/810942.PDF. 
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Whether used for medicinal or recreational purposes, many drugs 
can impair a person’s ability to drive.  Millions of people in the 
United States and worldwide continue to take drugs, both licit and 
illicit, before driving a car.6  A report released by The Substance 
Abuse and Mental Health Services Administration (SAMSHA) 
stated that in the United States, “nearly 10 million people drove 
under the influence of drugs during the preceding year, roughly 1/3 
of the number who reported driving under the influence of alcohol 
during the same time frame.”7  The Institute for Behavior and 
Health (IBH) provides the following estimate: “[Twenty percent] of 
crashes are caused by drugged driving.  That translates into 8,600 
deaths, 580,000 injuries, and $33 billion in property damage each 
year in the United States.”8  These drug-impaired drivers are caus­
ing accidents and deaths on the roadways in increasing numbers, 
and the statistics are hard to ignore.9  “Without exception, all illicit 
drugs have the potential to impair the cognitive and behavioral 
skills that allow a person to engage in normal daily activities, such 
as driving and working.”10  Additionally, the “[u]se of [prescription] 
drugs such as benzodiazepines and tricyclic antidepressants has 
been shown to more than double the risk of involvement in injuri­
6. In 2006, the National Survey on Drug Use and Health documented that 10.2 
million people age twelve and older reported driving under the influence of illicit drugs 
during the year prior to being surveyed. SUBSTANCE  ABUSE & MENTAL  HEALTH 
SERVS. ADMIN., U.S. DEP’T OF HEALTH & HUMAN SERVS., RESULTS  FROM THE 2006 
NATIONAL SURVEY ON DRUG USE AND HEALTH, NATIONAL FINDINGS 2 (2007), http:// 
oas.samhsa.gov/nsduh/2k6nsduh/2k6results.pdf. 
In a large study of almost 3,400 fatally injured drivers from three Australian
 
states (Victoria, New South Wales, and Western Australia) between 1990 and
 
1999, drugs other than alcohol were present in 26.7 percent of the cases.  These
 
included cannabis (13.5 percent), opioids (4.9 percent), stimulants (4.1 per­
cent), benzodiazepines (4.1 percent), and other psychotropic drugs (2.7 per­
cent).  Almost 10 percent of the cases involved both alcohol and drugs.
 
NAT’L  INST. ON  DRUG  ABUSE, U.S. DEP’T OF  HEALTH & HUMAN  SERVS., DRUGGED 
DRIVING 2-3 (2008), http://www.drugabuse.gov/PDF/Infofacts/driving08.pdf [hereinaf­
ter DRUGGED DRIVING] (footnote omitted). 
7. IBH PUBLIC POLICY STATEMENT, supra note 1, at 1 (citing SUBSTANCE ABUSE R 
& MENTAL HEALTH SERVS. ADMIN., RESULTS FROM THE 2007 NATIONAL SURVEY ON 
DRUG  USE AND  HEALTH: NATIONAL  FINDINGS (2008), http://oas.samhsa.gov/nsduh/ 
2k7nsduh/2k7results.pdf). 
8. Id. 
9. See Centers for Disease Control & Prevention, Impaired Driving, http:// 
www.cdc.gov/MotorVehicleSafety/Impaired_Driving/impaired-drv_factsheet.html (last 
visited Apr. 8, 2010) (“Drugs other than alcohol (e.g., marijuana and cocaine) are in­
volved in about 18% of motor vehicle driver deaths.  These other drugs are generally 
used in combination with alcohol.”). 
10. MARCELLINE BURNS, MEDICAL-LEGAL ASPECTS OF DRUGS 153 (2003). 
36 
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ous falls and traffic accidents.”11  While it is undisputed that the act 
of using drugs has an effect on one’s ability to operate a motor vehi­
cle safely,12 “the United States has invested little effort into com­
bating drug impaired driving.”13 
Unfortunately, the fight against drugged driving must over­
come many obstacles.  One of the biggest problems is the lack of 
uniformity regarding what exactly constitutes the crime of drugged 
driving.  Legislative inadequacies in drafting uniform OUI drug 
statutes and articulating clear guidelines that identify the applicable 
legal standards make it difficult to prove cases of drugged driving. 
In addition, members of the public are often unaware that operat­
ing a motor vehicle while under the influence of a licit drug that 
affects their ability to operate safely is a crime.14  This lack of 
awareness is compounded by the insufficiency of police expertise in 
detecting the crime, inadequate prosecutorial experience in prose­
cuting the crime, and the minimal amount of resources expended 
for combating OUI drugs.  It becomes obvious that without mean­
ingful change, lives will increasingly be lost to drug-impaired 
drivers. 
Part I of this Article briefly explains the history of impaired 
driving laws, with respect to both alcohol and drugs.  It then sets 
11. Id. at 170. 
12. “Drugs act on the brain and can alter perception, cognition, attention, bal­
ance, coordination, reaction time, and other faculties required for safe driving.” 
DRUGGED  DRIVING, supra note 6, at 3; see also Cameron Mostaghim, Roadside R 
Seizures of Medical Marijuana: Public Safety and Public Policy as Limitations Upon 
Transporting and the Return of Lawfully Seized Medical Marijuana, 36 W. ST. U. L. 
REV. 89, 98 (2008) (“[R]esearch has produced increasing evidence of significant impair­
ment of the driving ability of persons under the influence of cannabis.  Distortion of 
time perception, impairment of psychomotor function, and increased selectivity in at­
tentiveness to surroundings apparently can combine to lower driver ability.” (alteration 
in original) (quoting Ravin v. State, 537 P.2d 494, 510 (Alaska 1975)) (internal quota­
tion marks omitted)). 
13. Aaron J. Marcus, Are the Roads a Safer Place Because Drug Offenders Aren’t 
on Them?: An Analysis of Punishing Drug Offenders with License Suspension, 13 KAN. 
J.L. & PUB. POL’Y 557, 574 (2004). 
14. See PAUL A. MACLENNAN, AAA FOUNDATION FOR  TRAFFIC  SAFETY, 
OLDER ADULTS’ KNOWLEDGE ABOUT MEDICATIONS THAT CAN IMPACT DRIVING 3-4 
(2009), http://www.aaafoundation.org/pdf/KnowledgeAboutMedicationsAndDriving 
Report.pdf (discussing senior citizens as people who are following doctor’s orders with 
respect to dosage and usage but ignoring the advisory to avoid operating a motor vehi­
cle).  Others may follow instructions for particular prescriptions but ignore the effects 
of combining medications or combining medications with alcohol. See KATHY H. 
LOCOCO & LOREN STAPLIN, NAT’L HIGHWAY TRAFFIC SAFETY ADMIN., U.S. DEP’T OF  
TRANSP., IDENTIFYING  STRATEGIES TO  COLLECT  DRUG  USAGE AND  DRIVING  FUNC­
TIONING  AMONG  OLDER  DRIVERS 8-9 (2006), http://www.nhtsa.dot.gov/people/injury/ 
olddrive/DrugUse_OlderDriver/images/Job%202859%20Polypharmacy_New.pdf. 
37 
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forth the various frameworks currently in place to establish that an 
individual is OUI drugs and evaluates the effectiveness of each 
standard.  Part II discusses the impediments to detecting and prose­
cuting OUI drug cases.  This section details the difficulties associ­
ated with the science behind drugged driving, including determining 
the effect a drug may have on an individual as well as the validity of 
tests used to determine if one has a drug in their system.  Part II 
highlights the issues pertaining to laws that regulate OUI licit (pre­
scription or over-the-counter) drugs.  This section also discusses the 
impact that lack of funding and inadequate training for law enforce­
ment officers and prosecutors has on combating this crime.  Finally, 
Part III recognizes that targeting drugged driving is more compli­
cated than fighting OUI alcohol and suggests what is needed to 
combat this problem. 
I. HISTORICAL BACKGROUND OF IMPAIRED DRIVING LAWS 
For over 100 years, the act of consuming alcohol has been rec­
ognized as having a negative effect on one’s ability to operate a 
motor vehicle.15  The first laws criminalizing OUI alcohol were en­
acted soon after the invention of the motor vehicle.16  In the early 
1900s, OUI alcohol laws typically punished the impaired driver with 
a fine or short jail sentence.17  Subtle changes were made to these 
15. See Eric J. Gouvin, Drunk Driving and the Alcoholic Offender: A New Ap­
proach to an Old Problem, 12 AM. J.L. & MED. 99, 100 (1986) (“Inebriates and moder­
ate drinkers are the most incapable of all persons to drive motor wagons.  The general 
palsy and diminished power of control of both the reason and senses are certain to 
invite disaster in every attempt to guide such wagons.” (quoting a 1904 editorial from 
the Quarterly Journal of Inebriety) (internal quotation marks omitted)). 
16. See JAMES JACOBS, DRUNK DRIVING: AN AMERICAN DILEMMA 57 (1989); see 
also Jeffrey Robert Connolly, Maas v. Department of Commerce and Regulation: Why 
Can’t South Dakota Curb Repeat Offenses of Driving Under the Influence?, 50 S.D. L. 
REV. 352, 357 (2005) (“Drinking and driving has been regulated in South Dakota nearly 
as long as driving itself.  South Dakota’s first drunk driving law, passed in 1913, simply 
prohibited driving while ‘under the influence of liquor.’”).  “[A]pproved on March 3, 
1913, [the law] stated, ‘It shall be unlawful for any person to operate or attempt to 
operate any automobile or other motor vehicle in this state while such person is under 
the influence of liquor.’” Id. at 357 n.48. 
17. See, e.g., An Act Relative to Automobiles and Motor Cycles, ch. 412, § 4, 
1906 Mass. Acts 419, 422. 
Whoever operates an automobile or motor cycle on any public way or 
private way laid out under authority of law recklessly or while under the influ­
ence of intoxicating liquor, or so as to endanger the lives or safety of the pub­
lic, shall be punished by a fine not exceeding one hundred dollars or by 
imprisonment for a term not exceeding six months.  A conviction of a viola­
tion of this section shall forthwith be reported by the court or trial justice to 
the commission which shall immediately revoke the license of the person so 
38 
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laws over the ensuing years, with the most drastic changes starting 
in the 1980s.  As a result of pressure exerted by the National 
Highway Traffic Safety Administration (NHTSA) and the federal 
government, in the 1980s, almost every state in the United States 
passed stricter OUI laws.18  Alarmed by the impact of alcohol-
impaired driving, the federal government employed its spending 
powers to facilitate state action regarding the creation of these 
stricter OUI laws.19  These laws included: mandatory minimum 
sentences for repeat OUI drivers, suspension or revocation 
of an individual’s license to operate a motor vehicle upon convic­
tion for a first OUI offense,20 confiscation of the vehicle’s license 
convicted.  If it appears by the records of said commission that the person so 
convicted is the owner of an automobile or motor cycle, or has exclusive con­
trol of any automobiles or motor cycles as a manufacturer or dealer, said com­
mission shall thereupon revoke the certificate of registration of all 
automobiles or motor cycles so exclusively owned or controlled.  No new li­
cense or certificate shall be issued by said commission to such person until 
after sixty days from the date of such conviction, nor thereafter except in the 
discretion of said commission. 
Id. 
18. See 2 ENCYCLOPEDIA OF  CRIME AND  PUNISHMENT 548-49 (David Levinson 
ed., 2002). 
Forty-one states created commissions or task forces in 1981 to 1982 to examine 
the problem of drinking and driving, and the recommendations that they is­
sued led to the legislative enactment of tough laws that dramatically increased 
criminal and civil penalties for DUI offenses. . . . By 1985, state legislatures 
had enacted more than 1,000 DUI statutes. . . . Between 1980 and 1990, no 
area of the law received more attention or more nationwide legislative activity 
than did laws governing intoxicated drivers. 
Id. at 549. 
19. For example, in 1984, Congress successfully demanded, under The National 
Minimum Drinking Age Act, that each state require all purchasers of alcohol to be at 
least twenty-one years old. See 23 U.S.C. § 158 (2006).  If a state did not enact this 
legislation by 1986, the state would not be eligible to receive federal highway construc­
tion funds. Id.; see, e.g., Act of October 1, 1986, Act 207, 1992 Haw. Sess. Laws 549 
(making permanent a 1986 amendment that had temporarily raised the minimum drink­
ing age to twenty-one); see also 23 U.S.C. § 163 (enacted to encourage states to lower 
the legal BAC level from 0.10 to 0.08). 
The law, passed under the [government’s] spending power, allow[ed] the gov­
ernment to withhold 2 percent from federal highway funds, starting in 2004, if 
states [did] not comply with the federal mandate.  Each subsequent year, until 
2007, an additional 2 percent [would] be withheld from states that [were] not 
in compliance.  Therefore, any state that [did] not pass legislation to lower the 
BAC to 0.08 [would] have 8 percent of their state’s federal funding withheld in 
2007, and each subsequent fiscal year thereafter. 
Christopher O’Neill, Legislating Under the Influence: Are Federal Highway Incentives 
Enough to Induce State Legislatures to Pass a 0.08 Blood Alcohol Concentration Stan­
dard?, 28 SETON HALL LEGIS. J. 415, 416 (2004). 
20. NATIONAL SURVEY OF STATE LAWS 129 (Richard A. Leiter ed., 4th ed. 2003); 
see also MARGARET C. JASPER, DRUNK DRIVING LAW 33 (1999); OFFICE OF THE SEC’Y, 
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plates,21 requiring ignition interlock devices,22 and vehicle forfei­
ture.23  It is clear that the legislature has, at a minimum, made some 
effort to make OUI alcohol legislation effective.  Unfortunately, 
the existing legislation has failed to be effective in combating the 
crime of OUI.24  This is particularly true in terms of OUI drugs. 
While recognizing that drugged driving is a grave problem that 
must be researched and addressed,25 the federal government has 
not been proactive in passing legislation regarding OUI drugs.  The 
first piece of legislation that contemplated the issue of drug-
impaired driving was the Federal-Aid Highway Act of 1973.26  This 
Act authorized the Secretary 
to carry out safety research of the following: (1) [t]he relationship 
between the consumption and use of drugs and their effect upon 
highway safety and drivers of motor vehicles; and (2) [d]river be­
havior research, including the characteristics of driver perform­
ance, the relationships of mental and physical abilities or 
disabilities to the driving task, and the relationship of frequency 
of driver accident involvement to highway safety.27 
In 1988, Congress passed implied-consent legislation mandat­
ing that motorists who operate a motor vehicle in the special mari­
time and territorial jurisdiction of the United States and refuse to 
give consent to chemical testing to determine if they are under the 
influence of drugs or alcohol “shall be denied the privilege of oper­
ating a motor vehicle upon the special maritime and territorial juris-
U.S. DEP’T OF  TRANSP., PRESIDENTIAL  INITIATIVE FOR  MAKING .08 BAC THE  NA­
TIONAL  LEGAL  LIMIT: RECOMMENDATIONS FROM THE  SECRETARY OF  TRANSPORTA­
TION 20 (1998), http://purl.access.gpo.gov/GPO/LPS2320. 
21. See JASPER, supra note 20, at 36 (listing fourteen states that have laws author- R 
izing confiscation of license plates). 
22. Id. at 37 (explaining that an ignition interlock is a device that has a breath 
tester that drivers blow into to measure their blood alcohol level, and which, if alcohol 
is detected, prevents the vehicle from starting).  Thirty-seven states have such laws. Id. 
23. Id. (listing twenty-one states that have vehicle forfeiture laws). 
24. See Tina Wescott Cafaro, Fixing the Fatal Flaws in OUI Implied Consent 
Laws, 34 J. LEGIS. 99 (2008) [hereinafter Cafaro, Fatal Flaws]; Tina Wescott Cafaro, 
You Drink, You Drive, You Lose: Or Do You?, 42 GONZ. L. REV. 1 (2006). 
25. See 131 CONG. REC. S6323-04 (daily ed. May 16, 1985) (statement of Sen. 
Chafee).  Every year since 1981, the federal government has recognized a “National 
Drunk & Drugged Driving (3D) Prevention Month.” NAT’L  HIGHWAY  TRAFFIC 
SAFETY  ADMIN., U.S. DEP’T OF  TRANSP., HOLIDAY  MINI-PLANNER (FRIENDS) TALK­
ING  POINTS & FACT  SHEET 1 (2004), http://www.stopimpaireddriving.org/Holiday 
Planner/downloads/HolidaysFriendsFactSheet.pdf. 
26. See Federal-Aid Highway Act of 1973, Pub. L. No. 93-87, 87 Stat. 250 (codi­
fied as amended at 23 U.S.C. § 403(b) (2006)). 
27. Id. § 208. 
40 
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diction of the United States.”28  In 1991, the Alcohol-Impaired 
Driving Countermeasures Act provided a financial incentive to 
states to implement programs to help curtail impaired driving.29 
The Act provided that if a state implemented five or more enumer­
ated programs, then that state would qualify for federal program 
funding.30  One such program was a drugged-driving-prevention 
program.  In 2004, legislators were unsuccessful in their attempts to 
pass two bills mandating that all fifty states enact certain OUI drug 
laws.31  In 2005, federal legislation regarding OUI drugs was en­
acted with the purpose of facilitating the creation of a cohesive 
strategy to address OUI drugs.32  The federal government recog­
nized the growing concerns regarding this crime, the implications of 
doing nothing to combat impaired driving, and the difficulties in 
designing an effective strategy to fight it.  The problem is that, on a 
federal level, little has been done to combat the crime.  As a result, 
the task of addressing OUI drugs falls to the states. 
28.	 18 U.S.C. § 3118(b).  The statute also states, 
Whoever operates a motor vehicle in the special maritime and territorial 
jurisdiction of the United States consents thereby to a chemical test or tests of 
such person’s blood, breath, or urine, if arrested for any offense arising from 
such person’s driving while under the influence of a drug or alcohol in such 
jurisdiction. The test or tests shall be administered upon the request of a police 
officer having reasonable grounds to believe the person arrested to have been 
driving a motor vehicle upon the special maritime and territorial jurisdiction 
of the United States while under the influence of drugs or alcohol in violation 
of the laws of a State, territory, possession, or district. 
Id. § 3118(a). 
29.	 23 U.S.C. § 410. 
30.	 Id. 
31. House Bill 3907, introduced on March 4, 2004, sought to employ the federal 
government’s spending power to withhold funds from states that did not have 
mandatory minimum penalties for those convicted of OUI drugs.  H.R. 3907, 108th 
Cong. (2004).  House Bill 3922, The Drug Impaired Driving Enforcement Act of 2004, 
introduced on March 9, 2004, sought to mandate the sanctioning of any motorist operat­
ing a motor vehicle with any detectable amount of a controlled substance present in the 
person’s body.  H.R. 3922, 108th Cong. (2004). 
32.	 23 U.S.C. § 403(b). 
In addition to the research authorized by subsection (a), the Secretary, in 
consultation with other Government and private agencies as may be neces­
sary, is authorized to carry out safety research on the following: (1) The rela­
tionship between the consumption and use of drugs and their effect upon 
highway safety and drivers of motor vehicles.  (2) Driver behavior research, 
including the characteristics of driver performance, the relationships of mental 
and physical abilities or disabilities to the driving task, and the relationship of 
frequency of driver crash involvement to highway safety.  (3) Measures that 
may deter drugged driving.  (4) Programs to train law enforcement officers on 
motor vehicle pursuits conducted by the officers. 
Id. 
41 
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In some states, statutes prohibiting a motorist from driving a 
motor vehicle while under the influence of drugs have existed for 
almost as long as those prohibiting OUI alcohol.33  A look at these 
early statutes shows that from the inception of OUI drug laws, 
states have differed in drafting the most basic aspects of these laws. 
In New York, the first statute prohibiting OUI alcohol was passed 
in 1910, but it was one of the last states to enact an OUI drug stat­
ute in 1966.34  In California, one could not drive a vehicle if they 
were “a habitual user of narcotic drugs” regardless of whether or 
not they had consumed any drug prior to driving at a particular 
time.35  In West Virginia, the applicable standard generically for­
bade driving while intoxicated or under the influence of liquor, 
drugs, or narcotics.36  In Kansas, the statute made it “unlawful for 
any person under the influence of intoxicating liquor or any exhila­
rating or stupefying drug to drive, operate or have charge of the 
33. See Helmer v. Superior Court, 191 P. 1001, 1003 (Cal. Dist. Ct. App. 1920) 
(citing the Motor Vehicle Act of 1915, section 17, one of the earliest references to a 
state giving consideration to the dangers of OUI drugs); Black v. State, 130 S.E. 591, 
592 (Ga. Ct. App. 1925) (“[I]t is . . . an indictable offense for any person, ‘while under 
the influence of intoxicating liquors or drugs,’ to operate any motor vehicle upon any 
highway of this state, regardless of the rate of speed.” (quoting The Act of 1921, 1921 
Ga. Laws 255)); Newbauer v. State, 161 N.E. 826, 827 (Ind. 1928) ( “Any person who 
shall drive or operate a motor vehicle or motor bicycle on any highway of this state 
while under the influence of intoxicating liquor or narcotic drugs shall be deemed guilty 
of a misdemeanor . . . .” (quoting Acts of 1925, ch. 213, § 40) (internal quotation marks 
omitted)); State v. Ketter, 247 P. 430, 430 (Kan. 1926) (referring to state statute); State 
ex rel. Burkett v. Robinson, 123 S.E. 575, 576-77 (W. Va. 1924) (referring to section 88 
of chapter 43 of the state code, which went into effect on April 22, 1921). 
34. See People v. Litto, 822 N.Y.S.2d 130, 130-31 (App. Div. 2006) (“[I]n 1966, 
the [New York] Legislature added Vehicle and Traffic Law § 1192(4), making it a mis­
demeanor to operate a motor vehicle while impaired by the use of a drug.” (internal 
quotation marks omitted)).  In a letter to the Governor, the bill’s sponsor, Senator Nor­
man F. Lent, wrote, “[A]s presently written [the provision prohibiting driving while 
intoxicated] pertains to the operation of a motor vehicle while under the influence of 
alcohol,” and that “New York is one of the few remaining major states without a law 
against operating a motor vehicle while one’s ability is impaired by the use of drugs or 
narcotics.” People v. Grinberg, 781 N.Y.S.2d 584, 588 (Crim. Ct. 2004) (citation and 
internal quotation marks omitted). 
35. See Helmer, 191 P. at 1003.  In Helmer, the court cited the Motor Vehicle Act 
of 1915: “No person who is under the influence of intoxicating liquor and no person 
who is an [sic] habitual user of narcotic drugs shall operate or drive a motor or other 
vehicle on any public highway within this state.” Id. (internal quotation marks omit­
ted).  This statute appears to refer to an operator of a motor vehicle who is a habitual 
user, rather than exclusively referring to one who is operating under the influence of 
drugs. See id. 
36. See Burkett, 123 S.E. at 577 (“No person shall drive or operate any vehicle, 
motor driven or otherwise, upon any public road or street in this state, when intoxicated 
or under the influence of liquor, drugs or narcotics . . . .” (citation and internal quota­
tion marks omitted)). 
42 
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power or guidance of any automobile.”37  In New Jersey, the statute 
forbade operating a motor vehicle while under the influence of in­
toxicating liquor, narcotics, or habit-producing drugs.38  Statutes 
even differed on the definition of the terms “intoxicants” and “in­
toxication.”  In Oklahoma, the statute’s use of the terms “intoxi­
cant” and “intoxication” was held to refer to liquor only, and not 
drugs.39  In New York, the term “intoxication” was specifically held 
to refer to both liquor and other intoxicating agents.40 
As more became known about the effects of narcotics on an 
individual’s ability to operate a motor vehicle, some states enacted 
statutes that broadened the scope of what constituted an intoxicant. 
In Massachusetts, the first OUI drug law forbade the operation of a 
motor vehicle while under the influence of narcotics as defined by 
the state’s drug laws.41  Through the years, the definition of a nar­
cotic for purposes of the OUI law has become more explicit and the 
statute has enumerated more substances, including marijuana, bar­
biturates, amphetamines, other hypnotic or somnifacient drugs, va­
pors of glue, carbon tetrachloride, acetone, ethylene, dichloride, 
toluene, chloroform, xylene, or any combination thereof.42  How­
37. See Ketter, 247 P. at 430. 
38. State v. McCarty, 125 A. 138, 138 (N.J. 1923) (“No person shall operate a 
motor vehicle while under the influence of intoxicating liquor or any narcotic or habit-
producing drugs, or permit any person who may be under the influence of intoxicating 
liquor or narcotic or habit-producing drugs to operate any motor vehicle owned by him 
or in his custody or control . . . .” (citations and internal quotation marks omitted)). 
39. Sudderth v. State, 282 P. 1109, 1110 (Okla. Crim. App. 1929) (“True, intoxi­
cants might have a broader meaning than intoxicating liquors.  It might include certain 
narcotic drugs that would produce intoxication, but that is not the ordinary sense in 
which the term “intoxicants” is now generally used.  If one is spoken of as intoxicated, it 
will immediately be understood that such a one is under the influence of intoxicating 
liquors and not doped as is commonly used of narcotics.” (emphases added)). 
40. People v. Koch, 294 N.Y.S. 987, 989 (App. Div. 1937).  Appellant was con­
victed of a “violation of the Vehicle and Traffic Law, section 70, subdivision 5, as added 
by Laws 1933, c. 290, in that he operated a motor vehicle upon a public highway while 
in an intoxicated condition.” Id. at 988.  While Koch was held not to have violated the 
statute because he accidentally overdosed on medication that was properly prescribed, 
the court noted that “[t]he statute contemplates only voluntary intoxication resulting 
from imbibing alcoholic liquors or the voluntary taking into the system of other intoxi­
cating agents . . . . The term ‘intoxication’ includes also the condition produced by ex­
cessive use of agencies other than alcoholic liquor, when they are taken voluntarily.” 
Id. at 989-90. 
41. An Act Imposing a Penalty for Operating a Motor Vehicle While Under the 
Influence of Narcotic Drugs, ch. 422, § 2, 1961 Mass. Acts 240, 241. 
42. See MASS. GEN. LAWS ANN. ch. 90, § 24 (West 2008).  The history of additions 
to this statute includes the following: 
St.1961, c. 422, § 2, approved May 3, 1961, inserted “or narcotic drugs, as de­
fined in section one hundred and ninety-seven of chapter ninety-four” in the 
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ever, the Massachusetts OUI drug statute only allows for the prose­
cution of OUI drugs when a motorist operates a motor vehicle on a 
public way while under the influence of a scheduled drug as defined 
in chapter 94C, section 1 of the General Laws of Massachusetts.43 
Therefore, if an individual decides to drive on a public way while 
inhaling nitrous oxide, this would not constitute the crime of OUI 
drugs because nitrous oxide is not a scheduled drug, even though 
nitrous oxide, also referred to as laughing gas, “impairs psychomo­
tor and cognitive functioning.”44  While the legislature in Massachu­
setts has broadened the scope of what constitutes a drug for 
purposes of the state’s OUI drug statute, it struggles with the appli­
cation of this law.  The same is true in many other states. 
Nationwide, three different standards have been drafted in leg­
islation defining what constitutes OUI drugs: two “effect-based” 
laws and one “per se” law.45  The first effect-based law requires that 
an OUI drug motorist be rendered incapable of driving due to drug 
use.46  The second effect-based law requires a demonstration that 
an OUI drug motorist’s ability to operate a motor vehicle is im­
paired or that the motorist is under the influence or affected by an 
intoxicating drug while driving.47  Some per se laws set a limit on 
the amount of drug or drug metabolite in the driver’s system at the 
first sentence of par. (a) of subd. (1).  St.1962, c. 394, § 2, approved May 1,
 
1962, inserted “or under the influence of barbiturates, amphetamines, or other
 
hypnotic or somnifacient drugs” in the first sentence of par. (a) of subd. (1).
 
St.1963, c. 369, § 2, approved May 6, 1963, inserted “or under the influence of
 
the vapors of glue, carbon tetrachloride, acetone, ethylene, dichloride, tolu­
ene, chloroform, xylene or any combination thereof” in the first sentence of
 
par. (a) of subd. (1).
 
Id.; see also Commonwealth v. Green, 543 N.E.2d 424, 425-26 (Mass. App. Ct. 1989) 
(explaining the history behind the OUI drug statute prior to its amendment and chroni­
cling its incorporation of the “Uniform Controlled Substances Act, 9 Uniform Laws 
Annot. § 101(o) (Master ed. 1988), including its definition of ‘narcotic drug’”). 
43. MASS. GEN. LAWS ch. 90, § 24 (1)(a)(1). 
44. BURNS, supra note 10, at 148.  This example of driving while at the same time R 
inhaling nitrous oxide is born from a real case that was unsuccessfully prosecuted in the 
Springfield District Court, Hampden County, Massachusetts. 
45. See STATE OF KNOWLEDGE OF DRUG-IMPAIRED DRIVING, supra note 2, at 88. R 
46. Id.  States with this type of law include Alabama, Arkansas, Kansas, Mary­
land, New Mexico, North Dakota, Oklahoma, South Dakota, Vermont, and Wyoming. 
See ALA. CODE § 32-5A-191(a)(3) (LexisNexis Supp. 2009); ARK. CODE ANN. § 5-65­
102(2) (2005); KAN. STAT. ANN. § 8-1567(a)(4) (2001); MD. CODE ANN., TRANSP. § 21­
902(c)(1) (LexisNexis 2009); N.M. STAT. ANN. § 66-8-102 (West Supp. 2008); N.D. 
CENT. CODE § 39-08-01 (Supp. 2009); OKLA. STAT. ANN. tit. 47, § 11-902 (A)(3) (West 
Supp. 2010); S.D. CODIFIED  LAWS § 32-23-1(3) (Supp. 2009); VT. STAT. ANN. tit. 23, 
§ 1201(a)(3) (Supp. 2009); WYO. STAT. ANN. § 31-5-233 (a)(ii)(B) (2009). 
47. States with this type of law include Florida, Hawaii, Kentucky, Montana, and 
Massachusetts. See FLA. STAT. ANN. § 316.193 (West Supp. 2010); HAW. REV. STAT. 
44 
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time of the arrest.48  However, there was a lack of consensus as to 
the particular levels.  As a result, states with per se laws now em­
ploy a “zero tolerance” per se law.49  This zero tolerance per se law 
prohibits motorists from operating a motor vehicle if there is any 
detectable level of illicit drug or drug metabolite in their body, re­
gardless of whether the motorist operated the motor vehicle in an 
impaired manner. 
While all fifty states have laws that include sanctions for OUI 
drugs, these laws differ dramatically both in substance and applica­
tion.50  The majority of states have effect-based or “under the influ­
ence” statutes.51  Yet, as mentioned above, within this classification 
of effect-based laws, two different standards exist.  The first stan­
dard requires that the motorist be “incapacitated” by the drug, and 
the second requires that the motorist be “impaired” by the drug.52 
In order to prove that one is incapacitated, it must be demonstrated 
that the “influence of the drug ‘renders the driver incapable of 
safely driving’ . . . and the prosecutor must show a connection be­
tween the drug ingestion and the incapacity of the driver.”53  The 
requirement of proof in impairment cases is less stringent than the 
standard that a driver must be rendered incapable of safely driving, 
but proof must still exist that the driver’s impairment is directly re­
lated to the use of the drug.54 
Proving impairment or incapacity in OUI drug cases is often 
very challenging because it is difficult to establish “a nexus between 
the observed impairment and a drug as required by most state stat­
§ 291E-3 (LexisNexis Supp. 2009); KY. REV. STAT. ANN. § 189A.010 (LexisNexis Supp. 
2009); MASS. GEN. LAWS ch. 90, § 24; MONT. CODE ANN. § 61-8-406 (2009). 
48. See, e.g., NEV. REV. STAT. ANN. § 484.379 (LexisNexis Supp. 2007).  This stat­
ute originally provided a detailed list of prohibited substances and set forth the amount 
(in either urine nanograms per milliliter or blood nanograms per milliliter) of a prohib­
ited substance that constitutes a per se violation. 
49. See, e.g., ARIZ. REV.  STAT. ANN. § 28-1381(A)(3) (Supp. 2009); DEL. CODE 
ANN. tit. 21, § 4177(a)(6) (Supp. 2008); GA. CODE ANN. § 40-6-391(a)(2) (Supp. 2009); 
625 ILL. COMP. STAT. ANN. 5/11-501(a)(6) (West Supp. 2009); R.I. GEN. LAWS § 31-27-2 
(Supp. 2009); UTAH  CODE  ANN. § 41-6a-517 (2005); WIS. STAT. ANN. § 346.63 (West 
2005); The Governors Highway Safety Association, Drug Impaired Driving Laws (Apr. 
2000), http://www.ghsa.org/html/stateinfo/laws/dre_perse_laws.html. 




54. See id. 
45 
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utes.”55  Effect-based laws require law enforcement officers to em­
ploy a “driving under the influence of alcohol” approach, where 
officers evaluate a motorist suspected of driving under the influence 
of a drug in the same manner as they do an OUI alcohol suspect. 
This includes making observations of the motorist’s driving, appear­
ance, behavior, and coordination, and typically involves evidence 
regarding the defendant’s performance on standardized field sobri­
ety tests.  The officer will then be asked to give an opinion as to the 
motorist’s state of sobriety.  Under these statutes, the prosecution 
must typically produce evidence that identifies the specific drug 
used by the suspect.  With this comes a plethora of issues regarding 
opinion, expert, and scientific testimony.  As will be discussed in 
Part II, such testimony will likely require the use of Drug Recogni­
tion Experts (DREs). 
A per se law that sets specific limits of concentrations of drugs 
that are permissible in a person’s system, similar to the .08% blood 
alcohol content (BAC) limit in OUI alcohol cases, is easier to estab­
lish than an effect-based standard.  As discussed in Part II of this 
Article, several factors make setting per se levels difficult: the sheer 
number of different drugs that need to be tested to determine spe­
cific concentration limits; the science behind the correlation be­
tween the effects of drugs and blood plasma levels; individual 
sensitivities and tolerance levels; individual differences in absorp­
tion, distribution, and metabolism; acute versus chronic administra­
tion of the drugs; the effect of accumulation; and the effect of 
combining drugs, both illicit and licit.56 
A zero tolerance law is the easiest standard to prove, as this 
law makes it a criminal act to operate a motor vehicle while any 
proscribed substance is in one’s blood or system, regardless of the 
impact the drug has on one’s ability to drive.  Under zero tolerance 
laws, motorists only need to have a detectable amount of drug in 
their system to be guilty of OUI drugs.  Opponents of the zero tol­
erance law argue that the law is unjust because an individual would 
be guilty of OUI drugs if they have even a miniscule amount of 
55. THE WALSH GROUP, THE FEASIBILITY OF PER SE DRUGGED DRIVING LEGIS­
LATION: CONSENSUS  REPORT 5 (2002), available at http://www.walshgroup.org/FINAL 
%20CONSENSUS%20with%20inside%20cover%20text.pdf. 
56. RICHARD  COMPTON & AMY  BERNING, NAT’L  HIGHWAY  TRAFFIC  SAFETY 
ADMIN., TRAFFIC SAFETY FACTS: RESULTS OF THE 2007 NATIONAL ROADSIDE SURVEY 
OF ALCOHOL AND DRUG USE BY DRIVERS 3-4 (2009) [hereinafter ROADSIDE SURVEY], 
available at http://www.nhtsa.dot.gov/staticfiles/DOT/NHTSA/Traffic%20Injury%20 
Control/Articles/Associated%20Files/811175.pdf. 
46 
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drugs in their system regardless of the issue of impairment.  The 
example most often used is marijuana.  Marijuana’s primary active 
chemical is THC (delta-9-tetrahydrocannabinol), which is found in 
all forms of marijuana that are psychoactive.57  Because THC is ab­
sorbed and stored in fatty body tissue, including the brain, and due 
to the varying concentrations of THC, it is difficult to know the 
exact length of time traces are detectable in the body.58  However, 
full elimination of THC from the body can take several weeks while 
the peak effects of the drug appear after thirty to sixty minutes and 
typically last for two to four hours.59  For that reason, a motorist 
tested one week after using marijuana may still test positive al­
though the effects have long worn off.60 
Proponents of the zero tolerance law argue, “[T]he premise for 
the law is that the use of the drug is illegal, not that a specific con­
centration equates to impairment.”61  Consequently, by virtue of 
using an illegal substance, an individual has already broken the law 
and by driving after using this illegal substance, the charge of OUI 
drugs is warranted.62  Proponents also assert that a zero tolerance 
law puts drivers on notice that they must abstain from any illegal 
drug use prior to driving or face arrest.  Zero tolerance laws also 
take away the need for expert testimony regarding the levels and 
effects of illicit drugs.  In addition, these laws make getting a con­
viction in an OUI drug case a more certain outcome, which, in turn, 
has a deterring effect that will promote public safety. 




61. NAT’L HIGHWAY TRAFFIC SAFETY ADMIN., PRIORITIES AND STRATEGIES FOR 
IMPROVING THE INVESTIGATION, USE OF TOXICOLOGY RESULTS, AND PROSECUTION OF 
DRUG-IMPAIRED DRIVING CASES:  FINDINGS AND RECOMMENDATIONS 12 (2004) [here­
inafter PRIORITIES AND  STRATEGIES], available at http://www.decp.org/pdfs/ 
ImprovingDUICasesNHTSAReport.pdf. 
62. See Donna Leinwand, Growing Danger: Drugged Driving, USA TODAY, Oct. 
21, 2004, available at http://www.usatoday.com/news/nation/2004-10-21-cover-drugged­
driving_x.htm (reporting that John Walters, the past Director of the White House Of­
fice of National Drug Control Policy, argued that “authorities have to draw the line 
somewhere, and that a simple clear guideline—like that used to determine alcohol in­
toxication—is needed to combat drugged driving” and that “drugs such as cocaine and 
marijuana are illegal so a driver who tests positive likely has broken the law”). 
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A.	 The Need to Establish Scientific Standards for Drug 
Impairment 
OUI drug cases prove to be an extremely difficult area of the 
law to govern and prosecute.63  One of the primary reasons for this 
is that the nature of impairment in drug cases is not consistent. 
“There are three main categories of drugs based on their effects on 
the body: stimulants, hallucinogens and depressants . . . [and] each 
have different effects on driving ability.”64  Given the number of 
potentially impairing drugs, and because “[m]ost psychoactive 
drugs are chemically complex molecules, whose absorption, action, 
and elimination from the body are difficult to predict, and consider­
able differences exist between individuals with regard to the rates 
with which these processes occur,”65 determining which drugs and 
dosage levels impair driving-related skills is an overwhelming un­
dertaking.66  In OUI alcohol cases, the predictability associated 
with the side effects and the levels of impairment due to the con­
sumption of alcohol67 fostered the passing, by all fifty states, of a 
per se law providing that someone is guilty of operating under the 
63. EDWARD L. FIANDACH, HANDLING  DRUNK  DRIVING  CASES 2-2 (2d ed. 
1995). 
If it can be said that there is a single area of the law of operating offenses
 
which is incapable of a single rational standard, it is operating under the influ­
ence of drugs. The vast onslaught of drug usage in America has created a
 
problem of virtually insurmountable proportions.
 
By and large, this has been due to the dominant trend, if not the unavoid­
able need, of defining drug influenced operating offenses within the context of
 





64. See BURNS, supra note 10, for a detailed discussion of the many effects drugs R 
have on an individual. 
65. See ROADSIDE SURVEY, supra note 56; see also GOV’T OF W. AUSTL., DRUG R 
DRIVING  BOOKLET (2007) [hereinafter DRUG  DRIVING  BOOKLET], available at http:// 
www.officeofroadsafety.wa.gov.au/documents/DrugDrivingBooklet2007.pdf (detailing 
a list of stimulants (ecstasy, cocaine, and amphetamines), depressants (heroin, mari­
juana, alcohol, and tranquilizers) and hallucinogens (LSD) and the duration and effects 
of these drugs on individuals and their ability to drive). 
66. The NHTSA began research to identify methods for assessing impairment.  It 
states, “[L]aboratory research [is being] conducted . . . to measure the effect of drug 
dosage on driving-related skills.” ROADSIDE SURVEY, supra note 56, at 3. R 
67. Id. (“A strong relationship between BAC [blood alcohol content] level and 
impairment has been established, as has the correlation between BAC level and crash 
risk.”). 
48 
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influence of alcohol if their BAC is at a level of .08 or above.68 
However, the science behind the effects of drugs and the duration 
of these effects makes it difficult to adopt a blanket per se “under 
the influence” amount in OUI drug cases.  Establishing scientific 
standards is especially challenging with respect to illegal drug use, 
as researchers cannot ethically administer the doses of drugs typi­
cally taken by regular users.  Judge Roderick Kennedy of the New 
Mexico Court of Appeals described the differences between OUI 
alcohol and OUI drugs as follows: 
Alcohol is a substance which affects the brain in a broad, non­
specific fashion.  That is, alcohol acts on the entire brain when it 
is present, in a pretty much uniform, predictable fashion.  Drugs 
often (if not usually) don’t act as broadly.  Drugs act on specific 
areas, functions or receptors in the brain, and often with different 
results in different persons.  Poly-drug abuse only increases the 
possibilities. In a ‘normal’ drug case like possession or sale the 
problem pertaining to a drug is what it is.  In DUI/DRUG cases, 
the issue is what the drug does . . . . Both cases can deal with 
amount of a drug, but in the first instance, the problem is purely 
quantitative (how many units?), where the latter blends quantita­
tive considerations with qualitative—is the amount of drug 
enough to impair this person at the time the person is driving? 
. . . Quantifying driving behavior, quantifying drug doses which 
are sufficient to cause decreased ability to drive a car, and then 
relating them all is challenging, to say the least.  Add to this the 
differing statutory schemes nationwide (worldwide) concerning 
driving while under the influence of drugs and the universal facts 
become merely that drivers ingest drugs that impair driving abili­
ties, and drug-impaired drivers cause accidents.  How these 
things are handled is not universal.69 
Added to the already difficult job of determining how a spe­
cific drug impacts an individual is the fact that many people use 
more than one type of drug at a time.  Polysubstance use occurs 
when substances such as illicit drugs, prescription drugs, and over­
the-counter drugs are mixed at the same time, so that more than 
one substance is active in the body.  This also includes combining 
68. NAT’L  HIGHWAY  TRAFFIC  SAFETY  ADMIN., TRAFFIC  SAFETY  FACTS: IM­
PAIRED MOTORCYCLE OPERATORS INVOLVED IN FATAL CRASHES 1 (2005), available at 
http://www-nrd.nhtsa.dot.gov/Pubs/809939.PDF.  As of August 2008, “[a]ll 50 States, the 
District of Columbia, and Puerto Rico have by law created a threshold making it illegal 
[per se] to drive with a BAC of .08 g/dL or higher.” Id. 
69. THE  WALSH  GROUP, supra note 55, at 4 (omissions in original) (quoting R 
Judge Kennedy) (internal quotation marks omitted). 
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any of these drugs with alcohol, as small doses of a drug coupled 
with alcohol use may cause a greater level of impairment.70  Gener­
ally, combinations of drugs act together in four ways.  First, the 
combination can create an “additive effect” that produces an en­
hanced result.71  “Stimulants when combined with other stimulants 
greatly increase the associated side effects causing a greater false 
sense of confidence and risk-taking behavior.  When a depressant is 
combined with another depressant, it dangerously increases the as­
sociated side effects, drastically slowing reaction time and distorting 
the driver’s perception.”72  Second, the combination can produce 
“[a]ntagonistic [e]ffects” where the two drugs have exactly opposite 
effects.73  Third, the combination can produce “[o]verlapping 
[e]ffects” where each drug may affect the suspect in some distinct 
ways.74  Fourth, the combination can produce “[n]ull [e]ffects” 
where none of the drugs have a visible effect.75  There is also a pos­
sibility that the combination of drugs will act in a totally unexpected 
manner.  For example, “[h]allucinogens when combined with any 
drug can be very unpredictable and dangerous.  This is because they 
can cause visual distortion, including perceptions of speed and dis­
70. See LAWRENCE  TAYLOR & STEVEN  OBERMAN, DRUNK  DRIVING  DEFENSE 
§ 1.06, at 45 (6th ed. 2006) (“[T]he cumulative impairment [of small doses of alcohol 
and another drug] will probably be greater than expected.  This is a case of one plus one 
equaling three.”); Lawrence R. Sutton, The Effects of Alcohol, Marihuana and Their 
Combination on Driving Ability, 44 J. STUD. ON ALCOHOL 438, 442-43 (1983). 
71. MASS. CONTINUING  LEGAL  EDUC., 2 TRYING OUI CASES IN  MASSACHU­
SETTS, at A.V-12 (Hon. Kenneth J. Cote, Jr., ed. 2004) [hereinafter TRYING OUI CASES 
IN MASSACHUSETTS] (“For example, both CNS Stimulants and Hallucinogens dilate the 
pupils. A person who has combined a stimulant with a hallucinogen will exhibit dilated 
pupils.”). 
72. DRUG DRIVING BOOKLET, supra note 65, at 13. R 
73. TRYING OUI CASES IN MASSACHUSETTS, supra note 71, at A.V-12. R 
In combination, it can be difficult to predict which drug will exert the stronger 
effect. It is even possible that the opposing effects will mask each other for a 
time. 
For example, CNS stimulants usually cause pupil dilation, while narcotic 
analgesics usually cause pupil constriction. A person under the combined in­
fluence of a stimulant and a narcotic may have pupils that are nearly normal in 
size. And, it is possible that their pupils may be dilated at one time, and then 





74. Id. at A.V-12 to -13 (“In combination, both effect[s] may be observed.  For 
example, PCP enhances nystagmus, Narcotic Analgesics do not cause nystagmus.  A 
person under the influence of both drugs will exhibit nystagmus.”). 
75. Id. at A.V-13 (“For example, neither CNS Stimulants or Narcotic Analgesics 
enhance nystagmus. A person under the influence of these drugs would not exhibit 
nystagmus.”). 
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tance and greatly limit the accuracy of actions when driving.”76  Ad­
ditionally, combining a stimulant with a depressant produces a 
“dangerous masking effect”: if someone takes a drug like speed and 
combines it with alcohol, he or she may not feel intoxicated; how­
ever, his or her ability to drive will be affected.77 
B. Use of Roadside Devices to Determine Impairment 
Given the magnitude of the number of combinations of differ­
ent types of drugs and alcohol, it is easy to see why it is complicated 
to make a determination that an individual is under the influence of 
drugs.  Even absent polysubstance use, it is difficult for a law en­
forcement officer to make a determination that a motorist is under 
the influence of drugs.  Often times, the officer at first believes a 
motorist is under the influence of alcohol.  It is not until the motor­
ist takes a breathalyzer test resulting in a BAC indicating the ab­
sence of alcohol or a small amount of alcohol that the officer 
realizes that another substance may be in play.  It is at this point in 
the investigation that a roadside device to test for the presence of 
drugs would be useful. 
Unfortunately, a traditional breathalyzer test will not establish 
that one is under the influence of drugs.  In order to establish that 
drugs are present in one’s system, other tests such as blood, saliva, 
urine, sweat, and hair must be used.  Theoretically, a law enforce­
ment officer at the roadside can ask for any one of these samples of 
a suspected OUI drug motorist.  Realistically, the easiest samples to 
collect and test are sweat, saliva, and, if proper facilities are avail­
able, urine.  Developing devices, called roadside testing devices or 
point-of-contact-testing devices, that screen suspects for drug use 
and immediately provide drug test results has long been touted as 
one of the most important advances necessary to combat OUI 
drugs.78  Such testing devices do exist, and researchers continue to 
develop saliva and urine tests that will facilitate roadside testing for 
76. DRUG DRIVING BOOKLET, supra note 65, at 13. R 
77. Id. 
78. STATE OF  KNOWLEDGE OF  DRUG-IMPAIRED  DRIVING, supra note 2, at 16 R 
(“For more than twenty years, medical and traffic safety researchers have been aware 
that the prevalence of illegal drug use among impaired drivers, especially those in mo­
tor vehicle crashes, is not negligible.  However, the lack of forensic resources and tech­
nology to routinely and rapidly test for drugs has limited efforts to accurately document 
the scope of the problem or enforce DUID laws. There have been significant technolog­
ical advances in drug testing technology during the last five years, but generally this new 
technology has not been integrated into DUID enforcement or crash investigations.” 
(citation omitted)); see also Marcus, supra note 13, at 574 (“The object is to develop low R 
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drugs.79  However, the question remains as to exactly what type of 
drugs these tests should screen for.  Presently, most devices only 
screen for illicit narcotics, but as will be discussed later in this sec­
tion, many prescription and some over-the-counter drugs can also 
impair an individual’s ability to operate a motor vehicle. 
Many other countries currently use “drugalyzers” to identify 
motorists who are driving with drugs in their system, and Great 
Britain is currently test piloting the use of such devices.80  In Great 
Britain, if a roadside “drugalyzer” produces a positive reading, the 
motorist is taken to the police station where a doctor will draw 
blood to confirm the presence of drugs.  The blood test results will 
then be used as evidence at trial.81  Similarly, in August 2008, the 
French government began a road testing program where over 
50,000 drug screening kits were distributed across France to be used 
by police to test motorists for OUI drugs.  A motorist is required to 
deposit a saliva sample on a stick, “which is then dipped in a chemi­
cal substance to test for the presence of marijuana, ecstasy, cocaine, 
heroin, or amphetamines.”82  Such noninvasive tests detect the 
presence of drugs in approximately five minutes.83  In Australia, sa­
liva testing is deemed an accurate and reliable method for detecting 
the recent consumption of marijuana, speed, and ecstasy, and it is 
sensitivity roadside testing kits that detect drug metabolites at rates only exceeding pre­
determined threshold values.”). 
79. Laura June, Philips to Unveil Saliva-Based Roadside Drug Test Later This 
Year, ENGADGET, Aug. 6, 2009, http://www.engadget.com/2009/08/06/philips-to-unveil­
saliva-based-roadside-drug-test-later-this-yea/. 
In the vein of the breathalyzer, Philips has developed an on-the-go drug 
test, that can be used by the side of the road to test suspected imbibers for 
cocaine, heroin, cannabis, amphetamines and methaphetamine. Unlike the 
standard alcohol testing equipment, this one is used by having the suspect spit 
into a small receptacle, which is then inserted into the measurement chamber 
which contains magnetic nanoparticles coated with ligands that bind to one of 
five different drug groups, delivering color coded test results in about 90 
seconds. Philips, which has been developing the device since 2001, built it as an 
optical device that would be easy to mass produce for law enforcement. 
Id.; see also PETER WIERENGA, PHILIPS: RESEARCH FOR VALUE CREATION 18 (2007), 
http://www.philips.com/shared/assets/Downloadablefile/9_Peter_Wierenga_280907.pdf. 
80. For example, Romania, Australia, and Italy all employ roadside testing. 
David Millward, Motorists Face Roadside Drug Tests Under Government Plans, TELE­
GRAPH.CO.UK, May 10, 2009, http://www.telegraph.co.uk/motoring/5303341/Motorists­
face-roadside-drug-tests-under-Goverment-plans.html#. 
81. Id. 
82. Europe: French Police Start Saliva-Testing Drivers for Drugs, DRUG  WAR 
CHRON., Aug. 15, 2008, available at http://stopthedrugwar.org/chronicle/547/france_ 
drugged_driving_saliva_test. 
83. MOTOR ACCIDENT COMM’N, THE LOW DOWN ON DRIVING HIGH, available at 
http://www.mac.sa.gov.au/file.php?f=i66xRW.VHXjPX.91 (last accessed Mar. 8, 2010). 
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routinely given during roadside stops of suspected drugged 
drivers.84 
In the United States, roadside devices that test a motorist’s 
urine, sweat, or saliva are neither widely available nor widely used. 
Because of the lack of availability and use of these roadside devices, 
the scientific reliability of these devices has yet to be vetted by the 
courts.  Indeed, differences of opinion still exist among toxicologists 
regarding which specimen, other than blood, is the most appropri­
ate to test.85  In all European nations, “blood is considered the best 
fluid for confirmation analysis, because the presence of drugs in 
blood corresponds best with recent use and impairment.”86  How­
ever, after comparing the results of reference analysis in blood, 
urine, oral fluid, and sweat, it has been determined that use of urine 
and saliva also produces accurate results.87 
The European Union, with cooperation from four individual 
states of the United States, conducted a study from 2003 until 2005 
to evaluate the usability and analytical reliability of roadside saliva 
drug-testing devices.88  The study evaluated nine different brands of 
84. Id. 
85. PRIORITIES AND STRATEGIES, supra note 61, at 7. R 
86. U.N. INT’L  DRUG  CONTROL  PROGRAMME, RAPID  ON-SITE  SCREENING OF 
DRUGS OF  ABUSE 19 (2001) [hereinafter RAPID  ON-SITE  SCREENING OF  DRUGS OF 
ABUSE], available at http://www.unodc.org/pdf/scientific/Scitec18_final1.pdf. 
87. Id. at 19-20.
 
On the basis of the comparison between the results of reference analysis in
 
blood, urine, oral fluid and sweat, the following fluids seem suitable for on-site
 




Amphetamines: excellent agreement between urine, oral fluid and blood;
 
for sweat, the low numbers of samples do not allow a conclusion;
 
Benzodiazepines: urine gives moderately good results, for oral fluid, the
 
sensitivity needs to be improved and sweat was not tested;
 
Cannabinoids: better agreement with oral fluid than with urine. Urine has
 
a better sensitivity, but not a good specificity. Oral fluid has a sensitivity and
 
specificity of approximately 90%;
 
Cocaine: excellent for urine and oral fluid; for sweat, the low numbers of
 
samples do not allow a conclusion;
 
Opiates: slightly better agreement with oral fluid than with urine. Urine
 
has a better sensitivity (97%), but a lower specificity (85%).  Oral fluid has a
 
sensitivity and specificity of approximately 90%.
 
Id. 
88. ROSITA—2 PROJECT, FINAL REPORT 4 (Alan G. Verstraete & Elke Raes eds., 
2006), available at http://www.rosita.org/ (click link for “Executive Summary”). 
The study was carried out by National Institute for Criminalistics and
 
Criminology in Brussels, Belgium, the National Public Health Institute in Hel­
sinki, Finland, the Institute for Legal Medicine in Strasbourg, France, the In­
stitute for Legal Medicine in Homburg/Saar, Germany, the Division of
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devices administered to 2,046 subjects.89  Throughout the course of 
the study, 2,605 device evaluations were performed.90  All of the 
devices tested for the presence of the following illicit drugs: am­
phetamines, methamphetamine, marijuana, cocaine, and opiates, 
while three devices also had a test for prescription 
benzodiazepines.91  The study found that saliva was a good screen­
ing fluid for the presence or absence of amphetamines, marijuana, 
cocaine, and opiates in the body.92  However, the study exposed a 
number of impediments to the use of the devices: the failure rate of 
the devices, the sometimes too lengthy and complicated testing pro­
cedures, and the problems associated with the use of these devices 
during cold and rainy weather.93  “At the [conclusion] of the study, 
no device was considered to be reliable enough in order to be rec­
ommended for roadside screening of [motorists].”94  While research 
appears promising that saliva and other bodily fluid roadside testing 
can be accurate and indicative of drug use, further technological 
development and validation is needed before this testing will be 
generally accepted. 
When these devices do become available, law enforcement will 
be confronted with the issue of how to implement testing.  In addi­
tion to the practical issues that arise from administering roadside 
urine tests without proper facilities, several states refuse, on consti­
tutional grounds, to allow the compulsion of any tests.  Even 
Forensic Toxicology and Drug Abuse, Norwegian Institute of Public Health, 
Oslo, Norway and Institute of Legal Medicine, University of Santiago de 
Compostela, Spain.  It was coordinated by Ghent University, Ghent, Belgium. 
The study was performed in cooperation with the [United] States, where 
it is funded by The National Institute on Drug Abuse (NIDA), National Insti­
tutes of Health, US Department of Health and Human Services, the National 
Highway Traffic Safety Administration (NHTSA), US Department of Trans­
portation and the Office of National Drug Control Policy Executive Office of 
the President.  The US part is coordinated by The Walsh Group (Bethesda, 
Maryland).  The study is carried out in the following states:  Florida (Hillsbor­
ough County Sheriff’s Office, Florida Department of Law Enforcement, Man­
atee County Sheriff’s Office), Washington (Washington State Police, 
Washington State Toxicology Lab), Utah (Salt Lake City Police Department, 
Center for Human Toxicology) and Wisconsin (12 Police Jurisdictions, Wiscon­






93. Id. at 6. 
94. Id. 
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though the Supreme Court, in Schmerber v. California,95 allowed 
states to compel a motorist suspected of OUI alcohol to submit to a 
blood test as long as probable cause existed and the manner em­
ployed was reasonable under the circumstances, many states do not 
allow law enforcement to take this type of evidence by force.96  In 
fact, in some states a motorist cannot be compelled to provide a 
less-intrusive breath sample, and a refusal is met with little conse­
quence because the motorist’s refusal to take such a test is inadmis­
sible at trial.97  Given the state of the law in OUI alcohol cases and 
BAC tests, it seems unlikely that these states would compel an indi­
vidual to take a roadside drug test. 
C. Should OUI Drugs Include both Illicit and Licit Drugs? 
Prescription and over-the-counter drug use clearly contributes 
to the number of deaths and accidents caused by OUI drugs.98  In 
some instances, licit drug use more than doubles the risk of involve­
95. 384 U.S. 757, 758, 770-72 (1966). 
96. See, e.g., 75 PA. CONS. STAT. ANN. § 1547 (b) (1) (West 2006) (“If any person 
placed under arrest for a violation of section 3802 is requested to submit to chemical 
testing and refuses to do so, the testing shall not be conducted . . . .”); S.C. CODE 1976 
§ 56-5-2950 (2006) (“No tests may be administered or samples obtained unless the per­
son has been informed in writing that: (1) he does not have to take the test or give the 
samples . . . .”). But see United States v. Kincade, 379 F.3d 813, 849 n.6 (9th Cir. 2004) 
(“Some states have already passed legislation authorizing police to collect blood sam­
ples, with or without consent, from any driver reasonably suspected of drunk driving.”); 
see also Joseph T. Hallinan, In Fight to Stop Drunk Driving, Police Draw Blood, WALL 
ST. J., Mar. 23, 2004, at A1 (noting eight states that have passed legislation permitting 
similar procedures). 
97. See Jay M. Zitter, Annotation, Admissibility in Criminal Case of Evidence that 
Accused Refused to Take Test of Intoxication, 26 A.L.R. FED. 4th 1112 (1983) (providing 
a detailed study of the admissibility of BAC test refusals); see also MASS. GEN. LAWS ch. 
90, § 24(e) (2008) (“Evidence that the defendant failed or refused to consent to such 
test or analysis shall not be admissible against him in a civil or criminal proceeding, but 
shall be admissible in any action by the registrar under paragraph (f) or in any proceed­
ings provided for in section twenty-four N.”); Opinion of the Justices to the Senate, 591 
N.E.2d 1073, 1077-78 (Mass. 1992) (holding proposed legislation making admissible evi­
dence of a refusal to take a breath test unconstitutional). 
98. See NAT’L INST. ON DRUG ABUSE, NIDA, INFO FACTS: DRUGGED DRIVING 4 
(2009), available at http://www.drugabuse.gov/PDF/Infofacts/driving09.PDF. 
Prescription drugs: Many medications (e.g., benzodiazepines and opiate 
analgesics) act on systems in the brain that could impair driving ability. In fact, 
many prescription drugs come with warnings against the operation of machin­
ery—including motor vehicles—for a specified period of time after use. When 
prescription drugs are taken without medical supervision (i.e., when abused), 
impaired driving and other harmful reactions can also result. 
Id.; see also J Kaplan et al., Alcohol and Other Drug Use Among Victims of Motor-
Vehicle Crashes—West Virginia, 2004-2005, 55 MORBIDITY & MORTALITY  WEEKLY 
REP. 1293, 1295 (2006), available at http://www.cdc.gov/mmwr/PDF/wk/mm5548.pdf. 
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ment in motor vehicle accidents.99  As a result of the increase in 
drug-impaired driving, the NHTSA convened a panel of interna­
tional experts “to review developments in the field of drugs and 
human performance[,] . . . to identify the specific effects that both 
illicit and prescription drugs have on driving[,] and to develop gui­
dance for others when dealing with drug-impaired driving 
problems.”100  The NHTSA’s Report on Drugs and Human Per­
formance documented the conclusions of the panel and included 
the state of current scientific knowledge in the area of drugs and 
human performance for the sixteen drugs selected for evaluation.101 
Five licit drugs were evaluated: over-the-counter diphenhydramine 
(found in antihistamines and sleep aids such as Benadryl and 
Unisom); over-the-counter dextromethorphan (found in cough 
syrups and cold remedies such as Robitussin); prescription 
diazepam (commonly known as Valium); prescription zolipdem 
(commonly known as Ambien); and prescription carisoprodol and 
meprobamate (commonly known as Soma).102  Of these five 
drugs, three were determined to significantly impair one’s ability to 
drive: diazepam, diphenhydramine, and zolipdem.103  In fact, the re­
port concluded that over-the-counter diphenhydramine “has re­
peatedly been shown to severely impair tracking and reaction time 
The editors of Morbidity & Mortality Weekly Report described the prevalence of 
drugged driving in the West Virginia study: 
The effects of drugs other than alcohol on drivers have been studied by
 
laboratory testing of volunteers and epidemiologic studies comparing drug-

positive and drug-negative drivers after crashes. Results vary by type of
 
drug. . . .
 
. . . This report differs from previous reports in terms of the relatively high
 
prevalence of drugs among drivers in West Virginia and the finding that pre­
scription drugs (e.g., opioid analgesics and depressants) were more prevalent
 
than illicit drugs. In certain demographic groups of decedents, drugs were
 
more prevalent than alcohol.
 
Id. 
99. BURNS, supra note 10, at 170 (“Use of medicinal drugs such as R 
benzodiazepines and tricyclic antidepressants has been shown to more than double the 
risk of involvement in injurious falls and traffic accidents.” (citations omitted)). 
100. NAT’L HIGHWAY TRAFFIC SAFETY ADMIN., DRUGS AND HUMAN PERFORM­
ANCE FACT SHEETS 2 (2004) [hereinafter DRUGS AND HUMAN PERFORMANCE], availa­
ble at http://www.nhtsa.gov/people/injury/research/job185drugs/drugs_web.pdf. 
101. Id. (“The selected drugs include[d] over-the-counter medications such as 
dextromethorphan and diphenhydramine; prescription medications such as 
carisoprodol, diazepam and zolpidem; and abused and/or illegal drugs such as cocaine, 
GHB, ketamine, LSD, marijuana, methadone, methamphetamine, MDMA, morphine, 
PCP and toluene.”). 
102. Id. at 13, 25, 29, 35, 91. 
103. Id. at 16, 27, 32, 37, 94. 
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performance in actual on-the-road driving tests. . . . [It also] com­
pared the effects of a single oral dose of 50 mg diphenhydramine to 
the effects corresponding to a blood alcohol concentration of 0.1g/ 
100mL,” which is over the legal limit of .08%.104  In addition, all 
five of the licit drugs tested, when taken recreationally and not con­
sistent with a doctor’s instructions, produced impairment.105 
Impairment from licit drugs can parallel the symptoms of illicit 
drugs, “include[ing] poor perception, impaired reaction time, . . . 
confusion, disorientation, [marked drowsiness], inattentiveness, 
slurred or thick speech, slow [verbal] responses, lack of balance and 
coordination, unsteadiness, and difficulty standing [and] walk­
ing.”106  The increasing number of accidents associated with licit 
drug use and driving 
might reflect recent nationwide growth in the volume of prescrip­
tions for opioid analgesics and other potentially impairing medi­
cations. . . . These results might also reflect a recent increase in 
abuse of prescription drugs; the number of U.S. persons who 
started recreational use of opioid analgesics, sedatives, and tran­
quilizers in the previous year increased substantially from 1990 to 
2003.107 
As both licit drug use and the number of people driving under 
the influence of these drugs increases, legislation must be enacted 
to adequately address this issue. 
D. Inconsistencies in the Treatment of Licit Drugs 
The current application of states’ OUI licit drug laws is incon­
sistent.  As a result of the lack of uniformity, an unequal system is 
created wherein actions that would constitute an OUI offense in 
one state are legal in another.  One difference is in determining 
104. Id. at 37.  “Overall driving performance was the poorest after taking 
diphenhydramine, and participants were most drowsy after taking diphenhydramine 
(before and after testing). The authors concluded that diphenhydramine clearly impairs 
driving performance, and may have an even greater impact than does alcohol on the 
complex task of operating a motor vehicle.” Id. 
105. DRUGS AND HUMAN PERFORMANCE, supra note 100, at 16, 27, 32, 37, 94. R 
106. Id. at 16; see also DEP’T FOR TRANSP., ROAD SAFETY COMPLIANCE CONSUL­
TATION § 5.4, at 51 (2008), available at http://webarchive.nationalarchives.gov.uk/+/ 
http://www.dft.gov.uk/consultations/closed/compliance/roadsafetyconsultation.pdf 
(“Impairment includes adverse effects on judgment and self-confidence, and after­
effects—such as the extreme tiredness experienced in some cases—when the drug itself 
is no longer active.  These impairing effects can be increased if any drug is misused and 
if drugs are used in combination with each other.”). 
107. Kaplan et al., supra note 98, at 1295-96. R 
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what exactly constitutes a prohibited drug.  As discussed in Part I, 
Massachusetts only allows for the prosecution of OUI drugs when a 
motorist operates a vehicle on a public way while under the influ­
ence of a scheduled drug as defined in chapter 94C, section 1 of the 
General Laws of Massachusetts.108  If the drug used by the motorist 
is not a scheduled drug, then the OUI drug statute cannot be ap­
plied, regardless of how impaired the motorist was while driving, 
and, consequently, there is no “crime.”109  In California, it is illegal 
to drive while under the influence of any drug if the drug “affect[s] 
the nervous system, the brain, or muscles [of the individual] as to 
impair to an appreciable degree the ability to operate a vehicle in a 
manner like that of an ordinarily prudent and cautious person in 
full possession of his faculties.”110  Under California’s statute, it 
need not be a scheduled drug; it can be any drug that causes impair­
ment, including prescription and over-the-counter medicines or any 
substance with a mind- or body-altering effect that impairs driving 
ability.111  California also makes it a crime for anyone addicted to a 
drug, other than controlled substances authorized for replacement 
narcotic therapy, to drive a vehicle.112 
In OUI licit drug cases, a lack of uniformity also exists con­
cerning what the prosecution must prove and what defenses are 
available to an individual arrested for OUI drugs.  In Louisiana, in 
cases where over-the-counter and prescription drugs are at issue, 
the prosecutor must prove that “the influence is caused by the oper­
ator knowingly consuming quantities of the drug or drugs which 
substantially exceed the dosage prescribed by the physician or the 
dosage recommended by the manufacturer of the drug.”113  In Mas­
sachusetts, the quantity of the drugs taken is not an issue; however, 
the prosecution must establish that an individual knew or should 
have known that taking a prescribed substance would affect driving 
108. MASS. GEN. LAWS ch. 90, § 24(1)(a)(1) (2008). 
109. Commonwealth v. Ferola, 889 N.E.2d 436, 437 (Mass. App. Ct. 2008). 
The crime, which is legislatively created, does not criminalize operation under 
the influence of all narcotics, stimulants, or depressants, but only those “de­
fined in section one of chapter ninety-four C.”  Absent proof that the defen­
dant’s operation was impaired by a drug, depressant, or stimulant that is 
among those so defined, no statutory violation arises. 
Id. (citations omitted). 
110. People v. Torres, 93 Cal. Rptr. 3d 303, 307 (Ct. App. 2009) (alteration in 
original) (quoting People v. Canty, 90 P.3d 1168, 1174 (Cal. 2004) (internal quotation 
marks omitted)); see  CAL. VEH. CODE § 23152 (a) (West 2000). 
111. See Torres, 93 Cal. Rptr.3d at 307. 
112. Cal. Veh. Code § 23152 (c). 
113. State v. Kestle, 996 So. 2d 275, 278 (La. 2008) (citation omitted). 
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ability, because only voluntary intoxication is prohibited.114  The 
defendant may attempt to establish that his impairment was invol­
untary by “introducing evidence that he did not know of the possi­
ble effects of the medication on his driving ability, that he did not 
receive warnings as to [the medication’s] use, and that he had no 
reason to anticipate the effects which the drugs induced.”115  In 
Pennsylvania, the OUI drug statute sets forth a zero tolerance stan­
dard for driving with any amount of a Schedule I116 controlled sub­
stance in a person’s blood, but only applies a zero tolerance 
standard to prescription drugs (under Schedule II117 or III118) in a 
person’s blood if the drug was not prescribed to the individual.119  If 
an individual has a valid prescription for a particular Schedule II or 
Schedule III controlled substance, they can only be found guilty of 
OUI drugs if they are “under the influence . . . to a degree which 
impairs the individual’s ability to safely drive, operate or be in ac­
tual physical control of the movement of the vehicle.”120  In North 
114. Commonwealth v. Reynolds, 852 N.E.2d 1124, 1130 (Mass. App. Ct. 2006) 
(“[T]he Legislature did not intend to penalize a person . . . who drives after consuming 
a therapeutic dose of a prescription drug unaware of its possible effects.  Yet, we have 
not ruled out the possibility of imposing criminal liability in circumstances where, as 
here, the defendant had reason to know of the drug’s possible effects . . . .” (citations 
omitted)). 
115. Commonwealth v. Wallace, 439 N.E.2d 848, 852-53 (Mass. App. Ct. 1982); 
KIMBERLY A. FOGARTY, MASS. DIST. ATTORNEYS ASS’N, THE MASSACHUSETTS PROS­
ECUTORS’ MANUAL: OPERATING UNDER THE INFLUENCE (2008). 
116. 35 PA. STAT. ANN. § 780-104 (West 2003) (describing that a Schedule I con­
trolled substance has “a high potential for abuse, no currently accepted medical use in 
the United States, and a lack of accepted safety for use under medical supervision”). 
117. Id. (describing that a Schedule II controlled substance has “a high potential 
for abuse, currently accepted medical use in the United States, or currently accepted 
medical use with severe restrictions, and abuse may lead to severe psychic or physical 
dependence”). 
118. Id. (describing that a Schedule III controlled substance has “a potential for 
abuse less than the substances listed in Schedules I and II; well documented and cur­
rently accepted medical use in the United States; and abuse may lead to moderate or 
low physical dependence or high psychological dependence”). 
119. 75 PA. CONS. STAT. ANN. § 3802 (West 2006). 
120. Id.  Georgia has a similar statutory scheme. See GA. CODE ANN. § 40-6-391 
(West Supp. 2009).  The statute states, 
(a) A person shall not drive or be in actual physical control of any moving 
vehicle while:
 
. . . .
 
(2) Under the influence of any drug to the extent that it is less safe for the 
person to drive;
 
. . . .
 
(6) Subject to the provisions of subsection (b) of this Code section, there 
is any amount of marijuana or a controlled substance, as defined in Code Sec­
tion 16-13-21, present in the person’s blood or urine, or both, including the 
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Dakota, it is a defense to OUI licit drugs if “a drug which predomi­
nately caused impairment was used only as directed or cautioned by 
a practitioner who legally prescribed or dispensed the drug to that 
person.”121 
How the prosecution goes about proving that an individual is 
under the influence of a drug also differs between states.  Some 
statutes require the prosecution to identify the intoxicant and re­
quire expert testimony regarding exactly how that drug affects the 
body.  For example, in Pennsylvania, the prosecution must use ex­
pert testimony to establish that a prescription drug had an effect on 
an individual’s driving ability.122  However, other states are more 
lax and allow nonexpert testimony to establish that a motorist was 
under the influence of some intoxicant and that the intoxicant, 
whatever it may be, impaired diving ability.  For example, in State v. 
Kestle, the Louisiana Supreme Court held that there is no rule that 
requires expert training in recognizing drug intoxication and no rule 
requiring the State to prove that a specific substance caused the 
intoxication.123 
Another variation in OUI laws concerns how states address 
polysubstance use.  This has become a serious issue, as “drugs are at 
times taken in combination or with alcohol.  In an average week, at 
least 25% of U.S. adults take five or more prescription or over-the­
counter drugs, and 7% take five or more prescription drugs.”124 
Some OUI drug laws that require proof identifying the intoxicating 
drug fail to take into account that many times the impairment is 
metabolites and derivatives of each or both without regard to whether or not
 
any alcohol is present in the person’s breath or blood.
 
(b) The fact that any person charged with violating this Code section is or
 
has been legally entitled to use a drug shall not constitute a defense against
 
any charge of violating this Code section; provided, however, that such person
 
shall not be in violation of this Code section unless such person is rendered
 
incapable of driving safely as a result of using a drug other than alcohol which
 
such person is legally entitled to use.
 
Id. 
121. N.D. CENT. CODE § 39-08-01 (Supp. 2009); see State v. Bitz, 757 N.W.2d 565, 
567 (N.D. 2008). 
122. Commonwealth v. Griffith, No. 1315-MDA-2008, 2009 WL 1887535 (Pa. 
Super. Ct. July 2, 2009) (stating that the need for expert testimony is “necessitated by 
the inability of the trial court or any member of the jury to take notice of the effect of 
prescription medication on the human body, either alone or in combination with an­
other controlled substance”). 
123. State v. Kestle, 996 So. 2d 275, 282 (La. 2008). 
124. Kaplan et al., supra note 98, at 1296 (citing David W. Kaufman et al., Recent R 
Patterns of Medication Use in the Ambulatory Adult Population of the United States: The 
Slone Survey, 287 JAMA 337 (2002)). 
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attributable to a mixture of substances.  If a statute does not allow 
the prosecution of someone who is impaired due to using a combi­
nation of substances and any one substance alone did not cause the 
impairment, then the impaired motorist will not be held responsi­
ble.  In North Dakota, the OUI statute expressly accounts for situa­
tions where there is a combination of drugs and alcohol.125  In 
contrast, the Massachusetts statute does not.126  In order to prose­
cute a motorist for driving under the influence of a combination of 
drugs and alcohol in Massachusetts, that person must be charged 
with OUI alcohol, and the prosecution must rely on the portion of 
the law that states that alcohol only needs to be “‘one contributing 
cause of the diminished ability.’  Alcohol need not be the sole cause 
of the defendant’s impaired ability.”127 
The difficulties associated with prosecuting OUI licit drugs go 
deeper than the inconsistent application of laws.  The complexity of 
this crime is compounded by issues such as lack of roadside testing 
devices designed to detect licit drug use, lack of public awareness 
that certain licit drugs impair driving ability, and lack of public 
awareness that licit drug use can result in an arrest for OUI drugs. 
Further challenges include the large volume of prescription and 
over-the-counter drugs in existence, the number of people who take 
these drugs, and the lack of scientific testing regarding how each 
individual drug affects an individual.  These challenges make it ex­
tremely difficult to develop a strategy to combat both OUI licit and 
illicit drugs without adequately funding research and adequately 
125. See N.D. CENT. CODE § 39-08-01(1)(d). 
(1) A person may not drive or be in actual physical control of any vehicle 
upon a highway or upon public or private areas to which the public has a right 
of access for vehicular use in this state if any of the following apply: 
. . . . 
(d) That person is under the combined influence of alcohol and any other 
drugs or substances to a degree which renders that person incapable of safely 
driving. 
Id. 
126. See MASS. GEN. LAWS ch. 90, § 24 (2008).  In Massachusetts, there is no sep­
arate charge of OUI combination drugs and alcohol. See id.  In instances where there is 
evidence of some alcohol use, which appears to be compounded by drug use, the defen­
dant is charged with OUI alcohol. See id. 
127. Commonwealth v. Widmaier, No. 08-P-918, 2009 WL 1979967, at *1 (Mass. 
App. Ct. July 10, 2009) (citation omitted) (quoting Commonwealth v. Stathopoulos, 517 
N.E.2d 450, 453 (Mass. 1988)).  “It is enough if the defendant’s capacity to operate a 
motor vehicle is diminished because of alcohol, even though other, concurrent causes 
contribute to that diminished capacity.” Id. (quoting Stathopoulos, 517 N.E.2d at 453) 
(internal quotation marks omitted). 
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training law enforcement on how to investigate and prosecute these 
cases. 
E. Obstacles Confronted by Law Enforcement and Prosecutors 
Law enforcement officers are the frontline defense in the effort 
to combat OUI drugs.  When a motorist is stopped due to erratic 
driving, it is up to the officer to make a determination that an indi­
vidual is impaired.  However, when drugs are involved, many of­
ficers are ill equipped to properly investigate the cause.  As a result, 
impaired drivers are allowed to continue to drive.  It was situations 
such as this that prompted the creation of the NHTSA’s Drug Eval­
uation and Classification Program (DEC Program).128  The DEC 
Program is modeled after a program that was started in the early 
1970s by Los Angeles Police Officers.129  Officers in the LAPD 
were frustrated that many drivers who were clearly impaired by 
drugs were going unpunished because the officers lacked the train­
ing and experience to support their suspicions that drugs caused the 
impairment.130  As a result, members of the LAPD began to “col­
laborate[ ] with various medical doctors, research psychologists, and 
other medical professionals to develop a simple, standardized pro­
cedure for recognizing drug influence and impairment.  Their ef­
forts culminated in the development of a multi-step protocol and 
the first DRE [Drug Recognition Expert] program.”131 
The NHTSA soon took notice of this program and, along with 
the National Institute on Drug Abuse and various other agencies 
and research groups, began an examination of it.132  The overall 
conclusion of these studies was that DRE procedures provided 
trained police officers with the ability to accurately recognize the 
symptoms of many types of drugs used by drivers.133  As a result of 
128. The International Drug Evaluation & Classification Program, Drug Recog­
nition Experts (DRE): History and Development, http://www.decp.org/experts/ (last 
visited Mar. 26, 2010) [hereinafter IDECP]. 
129. Id. 
130. Id. 
131. Id.  A DRE “is a police officer [who is] trained to recognize impairment in 
drivers [who are] under the influence of drugs other than, or in addition to, alcohol.” 
Id. 
132. Id. 
133. THOMAS E. PAGE, L.A. POLICE DEP’T DRUG RECOGNITION EXPERT UNIT, 
THE DRUG RECOGNITION EXPERT (DRE) RESPONSE TO THE DRUG IMPAIRED DRIVER: 
AN OVERVIEW OF THE DRE PROGRAM, OFFICER, AND PROCEDURES pt. 1, available at 
http://www.ndaa.org/apri/programs/traffic/thomas_page_article_facts.html (last visited 
Mar. 26, 2010).  In 1996, the NHTSA reported to Congress that the DRE program “has 
been remarkably successful in producing meaningful results[,] . . . saving lives on our 
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these studies, in 1987, the NHTSA initiated pilot DEC Programs in 
four states134 and the next year added three more states.135  “[I]n 
1989, [the International Association of Chiefs of Police (IACP)] 
and [the] NHTSA expanded the DEC Program across the coun­
try.”136  Under the guidance of the IACP, as of November 2009, 
forty-six states, plus the District of Columbia, participate in the pro­
gram in the United States.137  Additionally, “three branches of the 
military, the Internal Revenue Service (IRS), and several countries 
around the world participate in the DEC Program.”138 
Becoming a DRE is a rigorous process.139  The DEC Program 
enables a police officer who is certified as a DRE to employ a stan­
nation’s roads[,] . . . gaining court acceptance[,] . . . and showing a steady return on 
investment.” Id. (omissions in original) (internal quotation marks omitted). 
134. IDECP, supra note 128 (Arizona, Colorado, New York, and Virginia).	 R 
135. Id. (Utah, California, and Indiana). 
136. Id. 
137. The International Drug Evaluation & Classification Program, Drug Recog­
nition Experts (DRE): State and Countries with DREs, http://www.decp.org/experts/ 
statescountries.htm (last visited Apr. 29, 2010).  Those states include Alabama (recently 
added to program), Alaska, Arizona, Arkansas, California, Colorado, Delaware, Flor­
ida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, 
Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Ne­
braska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, 
North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South 
Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, and Wyo­
ming. Id.  The four states currently not in the DEC Program are Connecticut, Michi­
gan, Ohio, and West Virginia. See id.; Telephone Interview with Chuck Hayes, DRE 
Coordinator, Int’l Ass’n of Chiefs of Police (Nov. 3, 2009). 
138. IDECP, supra note 128.	 R 
139. “A [DRE] must have successfully completed an approved course in the Stan­
dardized Field Sobriety Testing (SFSTs) before beginning the three-phase Drug Evalua­
tion and Classification (DEC) Program . . . .”  The International Drug Evaluation & 
Classification Program, Drug Recognition Experts (DRE): How Do I Become a DRE?, 
http://www.decp.org/experts/howdoi.htm (last visited Mar. 26, 2010).  The first phase of 
the program consists of a “16-hour DRE Pre-school, which includes an overview of the 
DRE evaluation procedures, the seven drug categories, eye examinations and profi­
ciency in conducting the SFSTs.” Id.  The second phase consists of a 
56-hour DRE School which includes an overview of the drug evaluation pro­
cedures, expanded sessions on each drug category, drug combinations, exami­
nation of vital signs, case preparation, courtroom testimony, and Curriculum
 
Vitae (C.V.) preparation.  At the conclusion of the 7-days of training, the of­
ficer must successfully complete a written examination before moving to the
 
third and final phase of training.
 
Id.	 In the third phase, 
the candidate DRE must complete a minimum of 12 drug evaluations under 
the supervision of a trained DRE instructor.  Of those 12 evaluations, the of­
ficer must identify an individual under the influence of at least three of the 
seven drug categories and obtain a minimum 75% toxicological corroboration 
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dardized twelve-step evaluation140 “to determine whether a suspect 
is under the influence of alcohol and/or drugs and, if so, what cate­
gory of drugs, by combining basic medical knowledge about drug 
pharmacodynamics with validated psychomotor tests.”141  A DRE 
must complete the entire twelve-step evaluation before reaching an 
opinion regarding what category or categories of drugs an individ­
ual has ingested.  This rigorous system 
is standardized in that all DREs, regardless of agency, utilize the 
same procedure, in the same order, on all suspects.  It is system­
atic in that it logically proceeds from a BAC, through an assess­
ment of signs of impairment, to toxicological analysis for the 
presence of drugs.  This procedure is rooted in standard medical 
procedures that are used to reach a diagnosis of illness or 
injury.142 
The creation and nationwide implementation of the DRE pro­
gram has alerted all officers, whether certified as DREs or not, that 
they need to be more aware of the warning signs of drugged driv­
ing.  If an officer who is not DRE-certified suspects that a motorist 
is under the influence of drugs, protocol is to call in a DRE to in­
vestigate.  Unfortunately, nationwide there are only 6,143 trained 
DREs.143  In a nation with roughly 18,000 police departments and 
approximately 732,000 fulltime sworn officers, this number of 
DREs is extremely low.144  In fact, most departments do not have 
rate.  The office [sic] must then pass a final knowledge examination and be
 
approved by two DRE instructors before being certified as a certified DRE.
 
Id. 
140. The International Drug Evaluation & Classification Program, Drug Recog­
nition Experts (DRE): The DRE Protocol, http://www.decp.org/experts/12steps.htm 
(last visited Feb. 13, 2010).  The twelve standardized evaluative steps utilized to assess a 
suspected OUI drug motorist are: (1) Breath Alcohol Test (a review of the Breath Al­
cohol Concentration to determine if alcohol is the cause of impairment, if not, then the 
DRE becomes involved); (2) Interview of the Arresting Officer; (3) Preliminary Exami­
nation (includes the first of three pulses); (4) Eye Examinations; (5) Divided Attention 
Tests; (6) Vital Signs Examinations (includes the second of three pulses); (7) Darkroom 
examinations of pupil size (includes an examination of the nasal and oral cavities); (8) 
Muscle Tone Examination; (9) Examination of Injection Sites (includes the third pulse); 
(10) Statements and Interrogation; (11) Evaluator Opinion; and (12) Toxicology Exami­
nation (obtaining a specimen and subsequent analysis). Id. 
141. AM. PROSECUTORS RESEARCH INST., THE DRUG EVALUATION AND CLASSI­
FICATION (DEC) PROGRAM: TARGETING  HARDCORE  IMPAIRED  DRIVERS 1 (2004), 
available at http://www.ndaa.org/pdf/drug_evaluation_classification_dec.pdf. 
142. PAGE, supra note 133, at pt. 3. R 
143. Telephone Interview with Chuck Hayes, DRE Coordinator, Int’l Ass’n of 
Chiefs of Police (Nov. 3, 2009). 
144. See BUREAU OF  JUSTICE  STATISTICS, U.S. DEP’T OF  JUSTICE, CENSUS OF 
STATE AND  LOCAL  LAW  ENFORCEMENT  AGENCIES 1 (2004), available at http:// 
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any drug recognition experts at all.  Because the vast majority of 
officers in the United States are not DREs and availability to call in 
a DRE is often very limited, evidence needed to prosecute an OUI 
drug suspect is often nonexistent. 
The low number of DREs is likely attributable to both the ex­
pense and time necessary to send an officer to DRE training.  In the 
state of Washington, the cost of this training is approximately 
$3,000 per student.145  Compounding this initial cost is the burden 
of maintaining the program, which is typically “not adequately sup­
ported with training, administrative or toxicological resources.”146 
There is also a large time commitment to becoming and remaining a 
certified DRE.  An officer must attend sixteen hours of the Drug 
Recognition Expert Pre-School, fifty-six hours of the Drug Recog­
nition Expert DRE School, and put in approximately forty to sixty 
hours for Drug Recognition Expert Field Certification (usually 
completed over several months).147  Once an officer is certified as a 
DRE, the officer must undergo recertification every two years.148 
In order to maintain proficiency, DREs “need to use their skills 
bjs.ojp.usdoj.gov/content/pub/pdf/csllea04.pdf.  In 2004, there were 731,903 sworn, full-
time police officers in 17,876 agencies nationwide. Id. at 2 tbl.2.  “There are currently 
45 DRE states participating in the program with over 8,000 DREs and instructors.” 
Iowa Department of Public Safety, The Iowa Drug Recognition Expert Program, http:// 
www.dps.state.ia.us/commis/gtsb/GTSBdre.shtml (last visited Apr. 8, 2010). 
145. This cost includes lodging, meals, equipment, and manuals.  Washington 
State Patrol Forensic Laboratory Services, Washington Drug Recognition Expert 
School Application, available at http://breathtest.wsp.wa.gov/ (select “DRE forms and 
manuals”; then select “DRE expert school application 6-09” under “forms” subsection) 
(last visited Apr. 8, 2010). 
146. PRIORITIES AND STRATEGIES, supra note 61. R 
147. The International Drug Evaluation & Classification Program, Drug Recog­
nition Experts (DRE): DRE Training & Certification, http://www.decp.org/training/ 
(last visited Apr. 8, 2010). 
148. Recertification requires a DRE to 
demonstrate continuing proficiency by: (1) Performing a minimum of four . . . 
acceptable evaluations since the date of last certification, all of which shall be 
reviewed and approved by a certified DRE instructor and one . . . of which 
shall be witnessed by a certified DRE instructor.  These evaluations may be 
performed on subjects suspected of drug and/or alcohol impairment or during 
class room simulations; and (2) Completing a minimum of eight hours of 
recertification training since the date of the DRE’s most recent certification, 
which may alternatively be presented in two sections of no less than four 
hours, and which shall be consistent with any IACP standards for such train­
ing; and (3) Presenting an updated Curriculum Vitae and rolling log to the 
appropriate coordinator or his/her designee for review. 
The International Drug Evaluation & Classification Program, Drug Recognition Ex­
perts (DRE): DRE Certification, http://www.decp.org/experts/recertification.htm (last 
visited Apr. 8, 2010). 
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regularly . . . [,] receive training concerning changes in the program, 
and stay informed about emerging patterns of drug use in their 
communities.  They also need the opportunity to testify regularly 
otherwise they lose confidence in their abilities to practice what 
they learned in training.”149 
The parameters of permissible DRE testimony differ between 
the states.  This is because there is no universal decision regarding 
whether the DRE protocol is scientific evidence and whether a cer­
tified DRE should be treated as an expert.  Some courts analyzing 
the DRE protocol under Frye150 or Daubert151 standards have de­
termined that it is scientific evidence that is subject to judicial 
gatekeeping,152 while other courts have held the DRE protocol is 
neither scientific nor novel.153  The federal court in the District of 
Nevada went so far as to say that the DRE protocol is not scientific 
and is no more than an officer making physical observations.154 
Courts that have determined that the DRE protocol is scientific 
have decided that the twelve-step evaluation process is generally 
accepted in relevant scientific communities and allow testimony if 
the witness is a qualified DRE.155  In Oregon, the court held that a 
DRE must complete all twelve steps of the DRE protocol before 
testimony of the procedures and results will be allowed in evi­
dence.156  This requirement poses a problem as the final step of the 
149. PRIORITIES AND STRATEGIES, supra note 61, at 5. R 
150. Frye v. United States, 293 F. 1013 (D.C. Cir. 1923). 
151. Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579 (1993). 
152. E.g., State v. Sampson, 6 P.3d 543, 549-50 (Or. Ct. App. 2000); State v. Baity, 
991 P.2d 1151, 1161 (Wash. 2000). 
153. E.g., Williams v. State, 710 So. 2d 24, 28 (Fla. Dist. Ct. App. 1998); State v. 
Klawitter, 518 N.W.2d 577, 584 (Minn. 1994); State v. Layman, 953 P.2d 782, 786 (Utah 
Ct. App. 1998). 
154. United States v. Everett, 972 F. Supp. 1313, 1319-20 (D. Nev. 1997). 
155. See Sampson, 6 P.3d at 551, 555-56; Baity, 991 P.2d at 1161 (“DRE evidence 
is admissible under Frye because it is generally accepted in the relevant scientific com­
munities. A properly qualified expert may use the 12-step protocol and the chart of 
categories of drugs to relate an opinion about the presence or absence of certain catego­
ries of drugs in a suspect’s system.”).  Many critics of the DRE protocol refer to it as 
“voodoo science” and argue that the protocol has not been accepted in the scientific 
community. See John B. Mancke, Driving Under the Influence (DUI) of Drugs Law 
Update, 80 PA. B. ASS’N Q. 99, 107 n.36 (2009) (setting forth the questions and concerns 
with the scientific validity and effectiveness of the DRE protocol). 
156. State v. Aman, 95 P.3d 244, 249 (Or. Ct. App. 2004).
 
[T]here is no evidence that the methodology employed—an 11-step DRE test
 
without toxicological confirmation—generally has been accepted in the rele­
vant field, has been used in a reported judicial decision, has a known rate of
 
error, is mentioned in specialized literature, or is not a novel, even singular,
 
employment in this state.  To the contrary, the omission of the corroborating
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DRE protocol calls for the suspect to provide a blood or urine sam­
ple and, often times, an individual is either unwilling or unable to 
produce such a sample.157  If a defendant refuses to produce such a 
sample, the entire test will not be allowed into evidence and a DRE 
will not be allowed to rely on the other eleven steps of the proce­
dure in forming an opinion as to impairment.158  Such a result 
makes it easy for defendants to thwart the process. 
Both the Arkansas and New York courts allow a properly cer­
tified DRE to testify as an expert.159  Washington courts will allow a 
properly trained DRE to give an opinion about the presence of a 
certain category of drug but will not allow testimony that predicts a 
specific level, and the DRE cannot “cast[ ] an aura of scientific cer­
tainty to . . . testimony.”160  In some states, a DRE is allowed to 
give an opinion that an individual is impaired but may not be re­
ferred to as an expert; instead, a DRE must be referred to as a 
drug-recognition evaluator, examiner, or officer.161  Other states 
have yet to address whether the DRE protocol is scientific evidence 
or whether a DRE’s testimony constitutes expert testimony.162 
Adding to the myriad of obstacles that frustrates law enforce­
ment officers’ ability to detect OUI drugs and present evidence in 
court is the lack of training prosecutors have with these cases.163 
OUI drug cases are inherently difficult to prosecute because they 
deal with a body of medical and pharmaceutical knowledge that is 
unfamiliar to many attorneys.  This lack of familiarity with a com­
toxicology report deprives the test of a major element of its scientific basis,
 





157. Id. at 248 (“According to the state, failure to obtain a urine sample for test­
ing will sometimes occur in the administration of the DRE protocol, ‘based on the na­
ture of the controlled substance a defendant has consumed.’”). 
158. Id. 
159. Mace v. State, 944 S.W.2d 830, 834 (Ark. 1997).
 
The circuit court specifically stated that it was qualifying [the police officer] as
 
an expert for a narrow purpose—whether [the defendant] was impaired be­
cause of some kind of intoxicant.  We agree that [the police officer’s] special­




Id.; People v. Villeneuve, 649 N.Y.S.2d 80, 83 (App. Div. 1996). 
160. State v. Baity, 991 P.2d 1151, 1160-61 (Wash. 2000). 
161. See, e.g., Williams v. State, 710 So. 2d 24, 37 n.23 (Fla. Dist. Ct. App. 1998); 
State v. Klawitter, 518 N.W.2d 577, 585-86 (Minn. 1994). 
162. Mancke, supra note 155, at 112 (“Whether the DRE officer’s testimony R 
qualifies as expert testimony under [PA. R. EVID. 702], has not been addressed by the 
appellate courts in Pennsylvania.”). 
163. PRIORITIES AND STRATEGIES, supra note 61, at 10. R 
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plex issue, coupled with large case loads, is a lethal combination 
that makes it difficult to successfully prosecute an OUI drug case. 
Without proper training on how to examine an expert witness (ei­
ther a DRE or toxicologist), how to understand toxicology reports, 
and how to interpret the state’s OUI drug statutes (which some 
state courts have yet to do), the ability to successfully prosecute 
OUI drug cases is nebulous at best. 
III. RECOMMENDATIONS 
It is clear that many variables make identifying and prosecut­
ing an OUI drug suspect a difficult task.164  It is also clear that 
courts have not agreed on how to handle the type of evidence and 
testimony that comes with an OUI drug case.  As a result, there is 
no “easy fix” to the issues that hamper the ability to successfully 
fight drugged driving.  There are, however, some steps that can 
move us in the right direction. 
We need to recognize that several of the tactics used to combat 
OUI alcohol—albeit an inherently easier crime to fight—can and 
should be used to fight drugged driving.  First, the public needs to 
become more aware that driving after taking drugs, whether illicit, 
prescription, or over-the-counter, is a safety risk that can amount to 
a violation of the law.  This can be done through public-awareness 
campaigns and by health care professionals and pharmacists taking 
a more active role in educating their patients about the risks of po­
tentially impairing medications.  New Zealand recently started a 
“pharmacy bag sticker” campaign.165  Whenever an individual fills a 
prescription, the bag displays the following notification: “Driving 
and drugs—important information: From 1st November 09, Police 
may carry out compulsory tests on drivers they suspect of driving 
under the influence of drugs.  For more information check with 
your pharmacist or prescription information.”166  Other countries 
have numerous television, radio, and print ads that highlight the 
dangers of drugged driving.167  In Australia, the government has 
164. See supra Part II. 
165. New Zealand Transport Agency, Drug-Driving Advertisements, http:// 
www.nzta.govt.nz/about/advertising/other/drug-driving.html (last visited Apr. 7, 2010). 
166. See Pharmacy Bag Sticker (on file with Western New England Law Review). 
167. See, e.g., Department for Transport, Drug Driving Awareness, http:// 
www.dft.gov.uk/think/drugdrive/home.shtml (last visited Apr. 8, 2010) (England, Ire­
land, and Scotland’s ad campaign proclaiming: “Drug Driving: Your Eyes Will Give 
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made a significant commitment to this campaign by funding these 
antidrugged driving public-awareness campaigns for ten years.168 
These campaigns address both driving after taking prescription or 
over-the-counter medicine and driving after taking illicit recrea­
tional drugs.169  Currently, public-awareness campaigns in the 
United States focus exclusively on consuming alcohol and driving, 
not on drug use and driving.  The need for public awareness is espe­
cially true regarding the use of licit drugs, as many people do not 
know that licit drugs can have an impairing effect on driving ability. 
Broadening impaired-driving awareness campaigns to include 
drugged driving and thus creating public awareness and under­
standing is the first step to combating the crime. 
Achieving public awareness of the risks of using drugs and 
driving must be coupled with vigorous and effective enforcement to 
promote deterrence.  In order to deter people from engaging in this 
conduct, the public needs to recognize that using drugs and driving 
is a crime that will likely end in arrest.  Therefore, law enforcement 
officers need to be trained to detect drug-impaired individuals and 
must be provided the necessary tools to do so.  To that end, more 
officers must be trained in the DEC Program as DREs.  The DRE 
program is the most effective tool currently available to law en­
forcement officers for the assessment and documentation of behav­
ior and impairment in drug-impaired drivers.  While this training 
may be costly, it is necessary for the detection and successful prose­
cution of these offenders.  In order to strengthen the DRE pro­
gram, more resources must be allocated to law enforcement 
agencies.  Money to finance this effort should come from both gov­
ernment subsidies and self-sustaining funds consisting of OUI 
offender-generated fees and fines.  These funds can be used to sup­
plement budgets and facilitate the more in-depth DRE training of 
law enforcement officers.  The funds should also be used to finance 
the research and development of roadside drug testing devices.  As 
we learned with OUI alcohol, portable breathalyzers used at the 
pageID=1553 (last visited Mar. 27, 2010) to view the history of Australia’s public educa­
tion campaign from December 2004 through its newest advertisement in July 2009: “If 
you drive on drugs you’re out of your mind.” 
168. See Queensland Government, Anti-Drug Driving, http://www.transport.qld. 
gov.au/Home/Safety/Road/Campaigns/Anti_drug_driving_campaign (last visited Mar. 
27, 2010). 
169. Id. 
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roadside are an important tool in confirming an officer’s belief that 
an individual is under the influence of alcohol.170 
In addition to training and properly equipping law enforce­
ment officers, there must be high visibility of OUI drug enforce­
ment programs.  This would include officers making a concerted 
effort to detect drug impairment at traditional OUI sobriety check­
points.  These checkpoints must be staffed by officers who are 
trained to detect and evaluate impairment based on drug use.  Once 
the public’s perception of the likelihood of arrest for this crime is 
raised, more people will likely think twice before using a drug and 
driving a car.  Because the deterrent effect created by an arrest will 
be short-lived if the public becomes aware that there is little likeli­
hood of conviction, prosecutors need to receive adequate training 
so that they can properly present an OUI drug case.  Prosecutors 
must be educated about expert testimony and scientific evidence, 
including how to establish a DRE’s background and qualify such an 
individual to give expert testimony in court, how to conduct a 
proper examination of a toxicologist, and how to read a toxicology 
report. 
Next, the standard used to determine if one is OUI drugs needs 
to be uniform.  We must recognize that a per se limit is not a viable 
option at this time because “current research does not enable one 
to predict whether a driver testing positive for a drug, even at some 
measured level of concentration, was actually impaired by that 
drug” while they were driving.171  Research should continue to be 
conducted to accurately define these impairment levels, after which 
standards need to be created on a national level. 
Because per se limit laws are not currently feasible, we must 
give a serious look at the adoption of a zero tolerance law.  The 
implementation of such a law will certainly serve the purpose of 
OUI laws: to ensure public safety by stopping drugged driving.  A 
zero tolerance law necessarily eases the burden of proving OUI 
drugs and is an effective tool in deterring motorists from operating 
after using drugs, but will likely draw fire regarding individual 
rights.  The net cast by this standard will undoubtedly catch people 
who are operating while impaired, but will also catch those who 
have traces of drugs in their system and are no longer under the 
influence of any drug.  Even so, this may be a palatable option for 
many, especially in instances where an individual is driving with an 
170. See supra Part II.B. 
171. STATE OF KNOWLEDGE OF DRUG-IMPAIRED DRIVING, supra note 2, at 85. R 
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illicit substance in his body.  In effect, a zero tolerance drug law is 
not punishing driving while impaired or under the influence, but 
creates a new crime of driving with any detectable amount of a drug 
in the body. 
The alternative to adopting a zero tolerance law is drafting a 
straightforward effect-based law that would be less difficult to pros­
ecute under.  Current effect-based laws that require testimony re­
garding the exact nature of the substance used and that limit the 
type of substances that qualify as an intoxicant fail to accomplish 
what they were designed to do: protect the public from unsafe driv­
ers.  The same is true of how some courts interpret the OUI drug 
statute.  Law enforcement officers must be allowed to testify re­
garding their observations and opinions concerning impairment. 
Judicial rulings that limit an officer’s ability to so testify render the 
prosecution unable to prove many of these cases.  Furthermore, the 
lack of uniformity regarding what constitutes under the influence 
and what evidence is admissible at trial creates an uncertain atmos­
phere regarding the likelihood of conviction.  It also creates illogi­
cal situations where what constitutes a crime in one state is legal in 
another.  To deal with this, the federal government must step in and 
wield its financial powers to compel the states to address these very 
serious issues.172 
Regardless of what OUI drug standard is adopted by a state, 
mandatory testing to confirm the presence of drugs in the body of 
motorists arrested for OUI drugs must be implemented.  Per se and 
zero tolerance laws necessitate such testing in order to prove that a 
drug or its metabolite is present in one’s system.  The manner in 
which effect-based laws are typically construed also necessitates 
such testing.  This is especially true in the case of a DRE’s twelve-
step evaluation process where the twelfth step requires obtaining a 
specimen for toxicological analysis. 
If an individual refuses to provide a sample, the state’s implied-
consent laws should be applied and the motorist’s license should be 
suspended.  All fifty states have implied-consent laws.173  The pur­
172. Congress has used its spending powers to effect change in alcohol-related 
laws in the past.  In 1984, Congress passed The National Minimum Drinking Age Act to 
push each state toward enacting a minimum legal age of twenty-one to purchase alco­
hol.  23 U.S.C. § 158 (2006).  In 2007, Congress passed legislation encouraging states to 
lower the legal BAC level from .10 to .08.  23 U.S.C. § 163. 
173. On October 4, 1972, the District of Columbia became the last of all the juris­
dictions to enact an implied-consent law. See S. REP. NO. 92-1262, at 4 (1972) (“Com­
parable provisions on ‘implied consent’ are now law in all of the States.  The District of 
Columbia is the sole remaining jurisdiction without an ‘implied consent’ law.”); see also 
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pose of these laws is to provide a strong inducement to submit to 
chemical testing to effectuate the state’s “interest in obtaining 
reliable and relevant evidence for use in subsequent criminal pro­
ceedings . . . [and to] promptly remov[e] such drivers from the road, 
. . . contribut[ing] to the safety of public highways.”174  Every state’s 
implied-consent law mandates that all operators of motor vehicles 
are deemed to have consented to a BAC test if there are reasonable 
grounds to believe that the driver is operating a motor vehicle while 
under the influence of alcohol.175  With the notable exception of 
Nevada, all states impose administrative sanctions for refusal,176 
setting forth “the statutory structure for suspending the license of a 
driver who refuses to submit to testing for alcohol concentra­
tion.”177  However, not every state’s implied-consent law mandates 
testing for the presence of drugs.  In Massachusetts, the implied-
consent law sets forth that operators of vehicles “shall be deemed 
to have consented to submit to a chemical test or analysis of [their] 
breath or blood in the event that [they are] arrested for operating a 
motor vehicle while under the influence of intoxicating liquor.”178 
When a state’s implied-consent law does not cover OUI drugs, it 
takes away an extremely important mechanism that law enforce­
ment can use to persuade motorists to submit to testing.  In doing 
so, the state is effectively precluding law enforcement from gaining 
the evidence needed to successfully prosecute an OUI drug case. 
Therefore, every implied-consent law must be drafted to apply to 
OUI drugs, and not just to alcohol. 
When an individual refuses to provide a sample to be tested for 
drugs, there must be severe sanctions.  Most states punish such re­
fusals with sanctions such as license suspension or revocation, but 
some states criminalize a refusal.  Criminalization of a refusal is an 
effective and reasonable strategy: “[I]mposing criminal sanctions to 
Matthew J. Dougherty, Casenote, Hays v. City of Jacksonville, 518 So. 2d 892 (Ala. 
Crim. App. 1987), 19 CUMB. L. REV. 177, 177 n.3 (1988) (citing the implied-consent 
laws of the fifty states). 
174. Motor Vehicle Admin. v. Richards, 739 A.2d 58, 68 (Md. 1999). 
175. See, e.g., MASS. GEN. LAWS ch. 90, § 24(1)(f)(1) (2008); 75 PA. CONS. STAT. 
§ 1547 (West 2006). 
176. U.S. DEP’T OF TRANSP., NAT’L HIGHWAY TRAFFIC SAFETY ADMIN., TRAF­
FIC  SAFETY  FACTS: BLOOD  ALCOHOL  CONCENTRATION  TEST  REFUSAL  LAWS (2007), 
available at http://www.nhtsa.dot.gov/people/injury/TSFLaws/PDFs/810723W.pdf. 
177. Motor Vehicle Admin. v. Shepard, 923 A.2d 100, 101 (Md. 2007); see also 
MD. CODE  ANN., TRANSP. § 16-205.1 (LexisNexis 2009); ROBERT B. MCKINNEY  & 
MARY  ANNE M. PAZANOWSKI, 3A MARYLAND  LAW  ENCYCLOPEDIA: AUTOMOBILES 
AND MOTOR VEHICLES § 96 (2007), available at MD-ENC AUTOS § 96 (Westlaw). 
178. MASS. GEN. LAWS ch. 90, § 24(1)(f)(1). 
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accompany the administrative penalty of loss of license or fine will 
increase the costs of refusing and thus encourage more people to 
take the . . . test.”179  If the purpose of the implied consent is to be 
realized, the sanction for refusal to test must be more than nominal, 
and whether administrative or criminal, must be no less than what it 
is for a positive test. 
CONCLUSION 
It is every driver’s responsibility to ensure that they are safe to 
drive.  When they are not safe to drive and do so anyway, it is the 
state’s responsibility to punish that behavior and deter it from hap­
pening again.  Lack of uniformity regarding what type of drugs trig­
ger an OUI drug offense, what proof is required to establish it, and 
what defenses are available all deter law enforcement from success­
fully fighting OUI drugs.  When that is coupled with a lack of train­
ing and experience for both law enforcement and prosecutors and a 
lack of resources directed to understanding, detecting, and combat­
ing the crime, it is clear that we are nowhere close to winning the 
war on OUI drugs.  Unless more research, more public awareness, 
and clearer laws are developed, drugged drivers will continue to slip 
through the cracks. 
179. Cafaro, Fatal Flaws, supra note 24, at 121. R 
